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ABSTRACT  
   
Birds have shown promise as models of diabetes due to health and longevity 
despite naturally high plasma glucose concentrations, a condition which in diabetic 
humans leads to protein glycation and various complications. Research into mechanisms 
that protect birds from high plasma glucose have shown that some species of birds have 
naturally low levels of protein glycation. Some hypothesize a diet rich in carotenoids and 
other antioxidants protects birds from protein glycation and oxidative damage. There is 
little research, however, into the amount of protein glycation in birds of prey, which 
consume a high protein, high fat diet. No studies have examined the potential link 
between the diet of carnivorous birds and protein glycation. The overall purpose of this 
study was to evaluate whether birds of prey have higher protein glycation given their high 
protein, high fat diet in comparison to chickens, which consume a diet higher in 
carbohydrates. This was accomplished through analyses of serum samples from select 
birds of prey (bald eagle, red-tailed hawk, barred owl, great horned owl). Serum samples 
were obtained from The Raptor Center at the University of Minnesota where the birds of 
prey consumed high protein, high fat, non-supplemented diets that consisted of small 
animals and very little to no carbohydrate. Serum was also obtained from one chicken for 
a control, which consumed a higher carbohydrate and antioxidant-rich diet. Glucose, 
native albumin glycation and antioxidant concentrations (uric acid, vitamin E, retinol and 
several carotenoids) of each sample was measured. Statistical analyses showed 
significant between group differences in percent protein glycation amongst the birds of 
prey species. Glycation was significantly higher (p < 0.001) in bald eagles (23.67 ± 
1.90%) and barred owls (24.28 ± 1.43%) compared to red-tailed hawks (14.31 ± 0.63%). 
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Percent glycation was higher in all birds of prey compared to the chicken sample and 
literature values for chicken albumin glycation. Levels of the carotenoid lutein were 
significantly higher in bald eagles and barred owls compared to great horned owls and 
red-tailed hawks and the carotenoids beta-cryptoxanthin and beta-carotene were 
significantly greater in bald eagles compared to red-tailed hawks and great horned owls. 
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CHAPTER 1 
INTRODUCTION 
Background. For the last several decades, worldwide diabetes mellitus prevalence 
has increased. In the United States alone in 2011-2012, it was estimated that 12-14% of 
adults had diabetes (both diagnosed and undiagnosed) while another 37-38% had 
prediabetes, the metabolic precursor to diabetes, bringing the total estimated number of 
people with either diabetes or prediabetes to 49-52% of the overall population (Menke, 
2015). With such a high prevalence, it is not surprising diabetes is a major cause of 
morbidity and mortality in the United States and costs the nation upwards of $245 billion 
annually in healthcare costs and loss of productivity (Menke, 2015; American Diabetes 
Association, 2013). Globally in 2013, diabetes and diabetes-related complications cost 
$549 billion or 11% of worldwide healthcare expenditures (International Diabetes 
Federation, 2013). It is projected the prevalence of type 2 diabetes in those under 20 
years old will quadruple in 40 years and, by 2040, approximately 592 million people 
worldwide will have diabetes (American Diabetes Association, 2014; International 
Diabetes Federation, 2013). These statistics highlight the need for continued research into 
the prevention and treatment of diabetes and diabetes-related complications.  
Hyperglycemia is the hallmark of diabetes. Chronically high levels of plasma 
glucose can cause microvascular damage of the retinas, kidneys and peripheral nerves 
leading to blindness, kidney disease and various neuropathies (Brownlee, 2001). In 
addition to these complications, hyperglycemia damages arteries, accelerates 
atherosclerosis and increases the risk of myocardial infarction, stroke, and limb 
amputation (Brownlee, 2001; Basta 2004). Micro- and macrovascular damage can be 
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caused by hyperglycemia-mediated glycation of plasma proteins, which then slowly 
undergo a series of reactions to form advanced glycation end products (AGEs) (Basta, 
2004). AGEs can form reactive oxygen species (ROS) and are implicated in the 
development of diabetic complications (Korwar et al., 2015; Brownlee, 2001; Basta, 
2004). AGEs accumulate in tissues and because of their stability, levels do not decrease 
even after hyperglycemia is corrected (Makita et al., 1991). This means the current 
treatment for diabetes, controlling plasma glucose levels, may not be enough to prevent 
further complications of the disease, due to AGE accumulation in the body that occurred 
before diagnosis and/or treatment. For this reason, further research into the prevention of 
protein glycation and AGE formation is needed. 
To fully understand the role of protein glycation in the pathogenesis of diabetic 
complications, appropriate animal models are needed. Due to the slow progression of the 
disease, during which time it can take years for symptoms of complications to manifest, 
conventional animal models, such as short-lived mice and rats, do not provide data that is 
comparable to humans (Szwergold & Miller, 2013). Longer-lived animals, such as 
monkeys and pigs, can pose logistical research problems that make long-term study both 
difficult and expensive (Szwergold & Miller, 2013). Birds as a class have been suggested 
as a fitting model for diabetes research. While in the past birds have been used to study 
aging, due to certain biochemical characteristics it has been proposed birds would also 
provide a useful model of diabetes (Szwergold & Miller, 2013). In fact, despite having 
higher metabolic rates, body temperatures and plasma glucose concentrations than 
mammals, birds are models of healthy aging as they outlive mammals of comparable 
body size by up to three times (Braun & Sweazea, 2008; Holmes, et al., 2001). Despite 
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these characteristics, birds are free of the pathologies that would arise in humans under 
the same circumstances. Discovering what protects birds from the deleterious 
consequences of naturally high plasma glucose concentrations would aid in creating new 
approaches to preventing and treating diabetes and its complications. Specifically, 
research into how birds prevent high levels of protein glycation despite their naturally 
high plasma glucose concentrations is integral to developing novel diabetes prevention 
and treatment strategies. 
Studies have found that despite having high plasma glucose concentrations, birds 
are resistant to the glucose-lowering effects of insulin (For review: Braun & Sweazea, 
2008) and have low levels of protein glycation (Holmes, et al., 2001). However, because 
many of the studies to date have used domestic species such as chickens, it is not known 
if the same is true for all species or wild birds. As granivores, chickens consume mainly 
grains and seeds. Thus, their overall diet is low in fat and protein (O’Donnell, 1978) and 
higher in carbohydrates and antioxidants. Birds of prey, on the other hand, consume a 
diet high in protein and fat. Intriguingly, some birds of prey, such as great horned owls 
and red-tailed hawks, have higher plasma glucose concentrations than chickens, which is 
attributed to higher rates of gluconeogenesis to compensate for low dietary carbohydrate 
intake (O’Donnell, 1978). Thus diet may be responsible for the difference between the 
birds of prey and chickens in this regard (O’Donnell, 1978). To our knowledge, no 
studies have examined a potential link between diet and protein glycation in birds. 
Research of this sort would be of interest to humans because it is widely accepted that 
diet and lifestyle contribute to the development and exacerbation of type 2 diabetes 
(International Diabetes Federation, 2013). An understanding of how specific nutrients 
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affect protein glycation in the presence of high plasma glucose concentrations is essential 
to discovering new therapies for humans in the prevention of complications that arise 
from protein glycation and AGEs in the course of diabetes. 
 Purpose of Study. The overall purpose of this research study was to evaluate 
whether birds of prey have higher protein glycation given their high protein, high fat diet 
in comparison to chickens which consume a diet higher in carbohydrates. This will be 
accomplished through analyses of serum samples from select birds of prey (bald eagle, 
red-tailed hawk, barred owl, great horned owl). 
 Research Aim and Hypotheses. The main research aim of this study was to 
evaluate native protein glycation in several birds of prey in comparison to chickens.  
  H1: Native protein glycation will be higher in birds of prey as compared to  
           chickens due to their high protein, high fat diet with limited  
           ingestion of antioxidants. 
  H2: Uric acid levels will be higher in birds of prey than chickens due to 
         higher ingestion and utilization of protein for energy. 
  H3: Carotenoid and antioxidant levels will be lower in birds of prey than  
            chickens due to low ingestion of antioxidants.  
 Definition of Terms. The following is a list of terms and the author’s definition of 
terms that are commonly used throughout this thesis. 
  AGEs – advanced glycation end products; irreversible compounds that 
form in the presence of hyperglycemia and promote the  
complications associated with diabetes. 
  Birds of prey – a predatory bird, distinguished by a hooked beak and sharp 
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talons. 
  Carnivore – an animal that eats a diet which consists mainly of the flesh  
   and tissues of other animals, which is high in protein and fat. 
  DAG-PKC pathway – during hyperglycemia, increased diacylglycerol  
   (DAG) from glycolysis activates protein kinase C (PKC) isoforms,  
   which can lead to retinal and renal blood flow abnormalities,  
   decreased production of nitric oxide in the kidneys, endothelial  
   dysfunction, vascular permeability, changes in vessel dilation and  
   basement membrane thickening. 
  GLUT-4 – the predominant insulin-responsive glucose transporter in 
mammals, which translocates from the intracellular space to  
the cell wall to facilitate glucose uptake from the blood in response  
to insulin binding to cell receptors. 
  Glucose auto-oxidation – in vitro, glucose is prone to transition metal- 
   catalyzed oxidation which generates reactive oxygen species that  
   in turn promote and contribute to overall protein glycation. 
  Glycation – non-enzymatic addition of sugars to proteins, lipoproteins and  
   nucleic acids. 
  Granivore – a type of herbivore that primarily eat seeds and grains and  
   therefore, consumes a relatively high carbohydrate, low protein,  
   low fat diet. 
Hexosamine pathway (HSP) – plays a small role in normal  
glucose metabolism; use is increased during hyperglycemia.  
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  Hyperglycemia – an excess of glucose in the bloodstream 
  Insulin resistance – condition in which the cells of the body become  
   resistant to the effects of the hormone insulin, thus causing glucose  
   to build up in the bloodstream. 
  Neuropathy – nerve damage that causes weakness or pain in affected area. 
  Nephropathy – kidney damage or disease. 
  Polyol pathway – pathway in which glucose is reduced to sorbitol and 
converted to fructose. 
  Prediabetes – the metabolic precursor to diabetes defined as having a  
   hemoglobin A1c between 5.7-6.4%, fasting plasma  
   glucose between 100-125 mg/dL or two-hour glucose during an  
oral glucose tolerance test (OGTT) between 140-199 mg/dL. 
  Protein kinase C (PKC) – a group of enzymes important in many cellular  
   functions and signal transduction pathways. 
  RAGE – receptors for AGEs; a molecule belonging to the 
immunoglobulin superfamily that has multiple ligands, including  
AGEs.  
  Reactive oxygen species (ROS) – highly reactive molecules, which in  
   excess quantities, can damage cells and tissues and lead to the loss  
   of physiological function. 
  Retinopathy – pathological damage to the retina of the eye. 
 Delimitations. Serum samples for specific birds of prey were used, thus the results 
may not be extrapolated to the whole animal or other birds, animals or humans. 
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Limitations. Some limitations of this study would be the use of serum from 
captive birds as opposed to wild birds and not manipulating the diet of the birds to 
determine a direct link between dietary modifications and glycation. Also, while the diet 
of the birds of prey consisted of small animals, it may not be representative of the type 
and predictability of feedings that birds of prey may experience in the wild. Because of 
inherent physiological differences between mammals and birds, findings from this study 
may not directly influence recommendations for humans, but may be used as a guide for 
further research and investigation.  
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CHAPTER 2 
REVIEW OF LITERATURE 
I. Diabetes Mellitus.  
Prevalence. For the last several decades, worldwide diabetes mellitus prevalence 
has increased. It is projected by the year 2035, approximately 592 million people 
worldwide will have or be affected by diabetes (International Diabetes Federation, 2013). 
The rate of diabetes has increased over time in every age group, in both genders, in every 
racial and ethnic group, as well as across all socioeconomic and education levels (Menke 
et al., 2015). It was estimated in the year 2013 alone, that an individual died from 
diabetes or its related complications every six seconds, totaling 5.1 million people 
(International Diabetes Federation, 2013). In the same year, diabetes and diabetes-related 
complications cost $549 billion or 11% of worldwide healthcare spending (International 
Diabetes Federation, 2013).  
In the United States in 2011-2012, it was estimated that 12-14% of adults had 
diabetes (both diagnosed and undiagnosed), while another 37-38% had prediabetes, the 
metabolic precursor to diabetes, bringing the total estimated number of people with either 
diabetes or prediabetes to 49-52% of the overall population (Menke, 2015). With such a 
high prevalence, it is not surprising diabetes is a seventh leading cause of morbidity and 
mortality among adults in the United States (National Center for Health Statistics, 2015) 
and costs the nation upwards of $245 billion in healthcare costs and loss of productivity 
(Menke, 2015; American Diabetes Association, 2013).  
People of all ages can be affected by diabetes although the majority of those 
diagnosed with diabetes are between the ages of 40 and 59 (International Diabetes 
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Federation, 2013). However, the prevalence of type 1 diabetes is increasing at a rate 
unexplained by genetic factors (Ramasamy et al., 2011; American Diabetes Association, 
2014); in 2013, more than 79,000 children had type 1 diabetes (International Diabetes 
Federation, 2013). In addition, the incidence of type 2 diabetes in adolescents is 
increasing, especially among those in minority groups (American Diabetes Association, 
2013). It is projected the prevalence of type 2 diabetes in those under 20 years old will 
quadruple in 40 years (American Diabetes Association, 2014). This is troubling because 
research shows individuals diagnosed with type 2 diabetes at a young age (15-30 years 
old) have greater rates of morbidity and mortality than those diagnosed in middle age 
(Al-Saeed et al., 2016). This increase in the early onset of diabetes in young people is 
alarming and highlights the need for continued research into the prevention and treatment 
of diabetes and diabetes-related complications for people of all ages. 
 Pathology. Diabetes is a disturbance in glucose regulation with hyperglycemia as 
its hallmark characteristic. In healthy individuals, glucose is regulated by the 
counterregulatory hormones insulin and glucagon. Insulin is produced by the beta cells of 
the islets of Langerhans in the endocrine pancreas; insulin enables glucose uptake into 
cells of insulin-dependent tissues, such as muscle and adipose, and is important in 
carbohydrate, lipid and protein metabolism (Wilcox, 2005) Insulin is mitogenic, meaning 
it supports and promotes cell division and growth and thus directs the anabolic processes 
of the fed state (Wilcox, 2005). Insulin deficiency, or resistance to its effects, leads to 
chronic hyperglycemia, which leads to the development of diabetes and diabetic 
complications.  
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 Diabetes is classified into four categories depending on the pathogenesis of 
chronic hyperglycemia according to the American Diabetes Association. The four 
categories are type 1 diabetes, type 2 diabetes, gestational diabetes mellitus (GDM), and 
‘other’, which includes diabetes due to genetic defects, diseases of the exocrine pancreas, 
and drug or chemical induced diabetes (American Diabetes Association, 2014).  
 Type 1 diabetes. Hyperglycemia of type 1 diabetes is precipitated by an 
autoimmune destruction of the beta cells in the pancreas, which leads to insulin 
deficiency (American Diabetes Association, 2014). Approximately 5% of all diabetes 
cases in the United States are type 1 diabetes (Centers for Disease Control and 
Prevention, 2014). There is a strong genetic factor in the development of diabetes; in twin 
studies, if one of the twins developed type 1 diabetes, the other twin had a ~50% chance 
of developing the disease (Hyttinen et al., 2003). It is thought the destruction of beta cells 
is autoimmune-mediated because patients with type 1 diabetes typically have antibodies 
to islet cells (Decochez et al., 2000). In fact, many studies have suggested measuring islet 
autoantibodies in relatives of those diagnosed with type 1 diabetes to determine if they 
too are at risk for developing the disease, since detection and diagnosis may limit 
complications and extend the time the pancreas produces insulin (American Diabetes 
Association, 2014). The onset of type 1 diabetes usually occurs in those younger than 20 
years old and is typically sudden, with individuals experiencing elevated levels of plasma 
glucose and often times, life-threatening ketoacidosis resulting from fatty acid oxidation 
in lieu of glucose (American Diabetes Association, 2014). Individuals with type 1 
diabetes require life-long treatment with exogenous insulin in order to control and 
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maintain safe levels of plasma glucose (Fullerton, et al., 2014). People with type 1 
diabetes will die without insulin (International Diabetes Federation, 2013). 
 Type 2 diabetes. This form of diabetes develops as a response to chronic insulin 
resistance and a progressive decrease in insulin production due to the resistance (Wilcox, 
2005). When plasma glucose levels are high, insulin is released from the beta cells of the 
islets of Langerhans in the pancreas into the bloodstream. One of the major roles of 
insulin is to facilitate the uptake of glucose into cells. This happens through increased 
insulin delivery of glucose to tissues via insulin-mediated vasodilation as well as insulin 
binding to its receptors in the cell membrane of muscle and adipose tissues where, 
through a cascade of intracellular signaling events, it stimulates the translocation of the 
insulin-responsive glucose transporter GLUT-4 to the plasma membrane to facilitate 
glucose uptake into the cell (Shepard & Kahn, 1999). The importance of GLUT-4 to 
glucose homeostasis has been shown in muscle-selective and adipose-selective GLUT-4 
knockout mice; these mice develop insulin resistance, glucose intolerance and impaired 
insulin action without GLUT-4 (Seki et al., 2003). Of note, glucose uptake in mammals 
can occur by two different processes; one is through the insulin-responsive GLUT-4 
pathway, another is through contraction-responsive GLUT-4, which is translocated to the 
cell wall due to muscle contraction (Shepard & Kahn, 1999).  
Insulin resistance is thought to be due to post-receptor defects in insulin signaling 
and glucose transporters (Shepard & Kahn, 1999; Wilcox, 2005); meaning insulin can 
bind to its receptors, but cell binding does not result in the translocation of GLUT-4.  
Individuals with type 2 diabetes are initially able to produce sufficient amounts of insulin, 
however, cellular response to insulin is diminished. Ultimately, insulin resistance results 
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in hyperglycemia because the cells are unable to take up glucose and thus levels in the 
blood remain high. Approximately 95% of all cases of diabetes are type 2 diabetes 
(Centers for Disease Control and Prevention, 2014). 
Progression of type 2 diabetes occurs slowly over a number of years and is often 
asymptomatic (American Diabetes Association, 2014; International Diabetes Federation, 
2013). Lifestyle factors such as over-nutrition and physical inactivity are risk factors for 
insulin resistance (Ramasamy, 2011) and are thought to influence a genetic pre-
disposition to the development of type 2 diabetes (Kujala, Kaprio, & Koskenvuo, 2002). 
Insulin resistance is positively correlated with body mass index, waist circumference, and 
waist-hip ratio increases (Wilcox, 2005). Moreover, high levels of free fatty acids in the 
blood from over-nutrition are associated with a decrease in insulin secretion and synthesis 
(Wilcox, 2005). Ageing, ethnicity, obesity and family history of diabetes are other risk 
factors for developing type 2 diabetes (International Diabetes Federation, 2013).  
Current treatment for those at risk of type 2 diabetes includes diet and lifestyle 
modifications as well as the use of drugs such as metformin, α-glucosidase inhibitors, 
orlistat and thiazolidinedione (American Diabetes Association, 2014). Lifestyle 
modification has been shown to be effective in decreasing the progression of diabetes, 
while the drugs mentioned decrease symptoms of diabetes to varying degrees (American 
Diabetes Association, 2014). Lifestyle modification and oral drug use are often enough to 
control plasma glucose concentrations, but some individuals also require insulin to 
maintain glucose control (International Diabetes Federation, 2013).  
Gestational diabetes mellitus. As the name implies, gestational diabetes occurs 
during pregnancy. Around the 24th week of pregnancy and throughout the third trimester, 
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a mother may develop insulin resistance most likely due to hormones from the placenta 
that are secreted to divert glucose and lipids to the fetus (International Diabetes 
Federation, 2013; Wilcox, 2005). Having gestational diabetes increases risks for both 
mother and infant. While gestational diabetes usually disappears after the birth of the 
child, the mother is at increased risk of preeclampsia and caesarean section, gestational 
diabetes with later pregnancies and development of type 2 diabetes (International 
Diabetes Federation, 2013). For the infant, gestational diabetes can lead to a larger than 
average size, putting the newborn at risk for shoulder injuries and breathing problems at 
birth (International Diabetes Federation, 2013). In addition, infants born to mothers with 
gestational diabetes are at increased risk for future obesity, development of type 2 
diabetes and other metabolic consequences (American Diabetes Association, 2013). In 
2013, it was estimated that globally 21 million births were affected during pregnancy by 
diabetes (International Diabetes Federation, 2013). Lifestyle modification is usually 
sufficient to manage hyperglycemia in 80-90% of women with gestational diabetes 
(American Diabetes Association), while a small number may require insulin or oral anti-
hyperglycemic medications (International Diabetes Federation, 2013).  
Other diabetes. Specific types of diabetes caused by factors other than immune 
destruction of beta cells or insulin resistance are relatively rare, comprising ~1-5% of all 
diabetes cases (Centers for Disease Control and Prevention, 2014). These other causes 
include genetic defects in either beta cell function or insulin action, and diseases such as 
cystic fibrosis (American Diabetes Association, 2014). Maturity-onset diabetes of the 
young (MODY) is an example of how genetic defects can cause diabetes; with this type 
of diabetes, abnormalities in any of the various genes responsible for insulin secretion can 
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be pathological (Timsit et al., 2016). Drugs or chemicals used to treat HIV/AIDS or used 
after organ transplantation can also induce diabetes (American Diabetes Association, 
2014). 
Diagnosis. Diagnosis of diabetes is based on meeting one of three testing criteria 
on two separate testing occasions. The three criteria are hemoglobin A1c (HbgA1c) ≥ 
6.5%, a fasting plasma glucose ≥ 126 mg/dL (7.0 mM/L), and a two-hour glucose during 
an oral glucose tolerance test (OGTT) ≥ 200 mg/dL (11.1 mM/L) (American Diabetes 
Association, 2014). Normal levels are HbA1c < 5.7%, a fasting plasma glucose < 100 
mg/dL (5.6 mM/L) and a two-hour glucose during an oral glucose tolerance test (OGTT) 
< 140 mg/dL (7.8 mM/L) (American Diabetes Association, 2014). 
For individuals who do not have diabetes but whose glucose levels are too high to 
be normal, the term “prediabetes” is used. Prediabetes is defined as having a HbA1c 
between 5.7-6.4%, an impaired fasting plasma glucose between 100-125 mg/dL (5.6-6.9 
mM/L) or an impaired two-hour glucose during an oral glucose tolerance test (OGTT) 
between 140-199 mg/dL (7.8-11.0 mM/l) (American Diabetes Association, 2014). 
Having prediabetes greatly increases the risk of type 2 diabetes and is also associated 
with the development of cardiovascular disease (International Diabetes Federation, 
2013). Prediabetes is not a clinical diagnosis, but is another risk factor associated with the 
development of type 2 diabetes and is associated with obesity, dyslipidemia with high 
triglycerides and/or low HDL, as well as hypertension (American Diabetes Association, 
2014).  
Complications associated with diabetes. Cardiovascular disease is the leading 
cause of morbidity and mortality among those with diabetes (American Diabetes 
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Association, 2014; International Diabetes Federation, 2013). Cardiovascular disease 
accounts for the majority of direct and indirect costs associated with diabetes (American 
Diabetes Association, 2014). Hyperglycemia, in combination with insulin resistance, 
damages the arteries that supply the heart and leads to accelerated atherosclerosis and 
increased risk of myocardial infarction and stroke (Brownlee, 2001; Basta 2004). Other 
cardiovascular diseases diabetics are at increased risk of are angina, peripheral arterial 
disease and congestive heart failure (International Diabetes Federation, 2013). At the 
microvasculature level, hyperglycemia promotes endothelial dysfunction and inhibits 
production of nitric oxide, a vasodilator and anti-atherogenic molecule (Brownlee, 2001). 
Endothelial cells are important in the health of the vasculature; these cells line the blood 
vessels and influence vessel tone and platelet function (Wilcox, 2005). In addition, 
hyperglycemia and insulin resistance are involved in the pathogenesis of diabetic 
dyslipidemia, which increases the likelihood of developing atherosclerosis and its 
associated risk of cardiovascular disease (Brownlee, 2001). Individuals with diabetes 
often have comorbidities which increase the risk of cardiovascular disease as well, such 
as hypertension, dyslipidemia, and family history of coronary disease; however, diabetes 
is an independent risk factor for cardiovascular disease (American Diabetes Association, 
2014).  
Chronic hyperglycemia leads to the development of disabling and life-threatening 
microvascular diseases (Cade, 2008; Brownlee, 2001, International Diabetes Federation, 
2013). Diabetes-specific microvascular pathologies can cause damage to the retinas, 
kidneys, and peripheral nerves and are thus the leading causes of blindness, kidney 
disease and failure, as well as various neuropathies (Brownlee, 2001). Clinical studies 
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show a strong relationship between glycemia and microvascular complications in both 
type 1 and type 2 diabetics (The Diabetes Control and Complications Trial Research 
Group, 1993) as the mechanisms responsible for the pathologies observed in the eyes, 
kidneys, and nerves are similar and follow the same pathways (Brownlee, 2001; Cade 
2008).  
Diabetic retinopathy is the most frequent cause of blindness in adults aged 20-74 
years (American Diabetes Association, 2014). Damage occurs to the retina, the macula, 
or both, and in severe cases, abnormal vessel growth appears (Cade, 2008). Severity of 
the retinopathy and damage to the eye is directly related to the length of time an 
individual has had diabetes and the degree of hyperglycemic exposure (American 
Diabetes Association, 2014; Hammes, 1991). Beyond hyperglycemia, factors that put 
diabetics at higher risk for retinopathy are hypertension and nephropathy (American 
Diabetes Association, 2014). Other factors associated with diabetic retinopathy are 
younger age of diabetes onset, insulin treatment, smoking, abnormal lipid profile and a 
high fat diet (Cade, 2008). It is estimated retinopathy takes as long as five years to 
develop from the onset of diabetes, a period in which individuals can be asymptomatic 
(American Diabetes Association, 2014), but nearly 100% of type 1 and type 2 diabetics 
are estimated to have pathological retinal changes within 15-30 years of having the 
disease (Hammes, 1991). Surprisingly, type 1 diabetics taking insulin have the highest 
prevalence of retinopathy, while type 2 diabetics diagnosed after 30 years of age have the 
lowest prevalence of retinopathy (Klein et al., 1984). The first marker of retinopathy is 
the loss of pericytes, cells which wrap around endothelial cells and capillaries and aid in 
capillary tone, growth and protection from reactive oxygen species (ROS) (Wilkinson-
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Berka, 2004). The exact mechanisms that lead to pericyte apoptosis are still being 
investigated, but oxidative stress, formation of advanced glycation end products (AGEs), 
activation of protein kinase C (PKC) and increased polyol pathway flux are thought to 
play a role in the development of retinopathy (Cai & Boulton, 2002). Hyperglycemic 
conditions promote pericyte loss and basement membrane thickening, thus weakening 
vessel walls, which allows micro-aneurisms and vascular leakage to occur (Wilkinson-
Berka, 2004) resulting in capillary blockage that leads to hypoxia and damage to the 
retina (Kohner, Patel & Rassam, 1995). 
Diabetic nephropathy also arises as a result of microvascular damage and occurs 
in 20-40% of those with diabetes (American Diabetic Association, 2014). Nephropathy 
will first manifest as microalbuminuria (elevated levels of albumin in the urine) which 
progresses to albuminuria, indicating renal dysfunction (Drummond & Mauer, 2002). 
Hyperglycemia promotes the thickening of glomerular basement membranes and triggers 
glomerular hyperfiltration which causes changes in the cellular matrix and advances to 
glomerular sclerosis and renal failure (Friedman, 1990). It has been observed that type 2 
diabetics who have microalbuminuria or a more advanced stage of diabetic nephropathy 
will experience a worsening of their condition at a rate of 2-3% a year (Alder et al., 
2003). Diabetic nephropathy is the leading cause of end-stage renal disease and its risk 
factors are similar to diabetic retinopathy; hyperglycemia, duration and age at onset of 
diabetes, dyslipidemia, hypertension and obesity (American Diabetes Association, 2014).  
Neuropathy, or nerve damage, is another serious complication of diabetes; at least 
one-half of people with diabetes have some form of neuropathy (Dyck et al., 1993). 
Nerve damage can manifest in a variety of different neuropathies including distal 
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symmetric neuropathy, diabetic autonomic neuropathy, cardiovascular autonomic 
neuropathy, gastrointestinal neuropathy and genitourinary tract disturbances (American 
Diabetes Association, 2014). This list illustrates how nerve damage can negatively affect 
numerous organ systems. Symptoms of neuropathy related to sensation include pain, 
burning and tingling sensations, numbness and loss of sensation, while other symptoms 
can include tachycardia, orthostatic hypotension, gastroparesis, and impaired 
neurovascular function (American Diabetes Association, 2014). Distal symmetric 
neuropathy, specifically, can cause severe and sudden pain and is associated with a lower 
quality of life, limited mobility, depression and social dysfunction (American Diabetes 
Association, 2014). Amputation and foot ulcerations are common in diabetic neuropathy 
due to a loss of lower-extremity sensation and peripheral vascular dysfunction (Boulton, 
1997). The risk of ulcers or amputation is increased in individuals who have had a 
previous amputation, past foot ulcer history, diabetic nephropathy, visual impairment, 
history of cigarette smoking and poor glycemic control (American Diabetic Association, 
2014). Hyperglycemia impairs neuronal microvasculature which is suspected to lead to 
the demyelination of neurons, hence the alterations in sensation (Cade, 2008). Pathologic 
traits present in neuropathy include pericyte, microfilament and axonal loss, basement 
membrane thickening, and decreased blood flow to C fibers, all of which lead to 
decreased perfusion and hypoxia of the connective tissue that surrounds the myelin 
sheath of each nerve fiber (Dyck & Giannini, 1996; Ibrahim et al., 1999; Malik et al., 
1993; Young et al., 1992). At this time, no specific treatment is available for nerve 
damage, other than glycemic control which may slow progression of neuropathy, but will 
not reverse nerve damage already sustained (American Diabetes Association, 2014).  
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As mentioned, current treatments for diabetes include diet and lifestyle 
modifications, insulin, and the use of drugs such as metformin, α-glucosidase inhibitors, 
orlistat and thiazolidinedione. These treatments have the goal of maintaining a safe level 
of plasma glucose concentrations to halt or delay the complications of diabetes, yet vary 
in their success of glycemic control. Reviews of the literature have shown that intensive 
glycemic control leads to better health outcomes and slows the progression of many of 
the complications associated with this disease (American Diabetes Association, 2014; 
Fullerton, 2014; Ramasamy, 2011). However, recent studies have found surprising 
outcomes of intensive glycemic control as intensive treatment of hyperglycemia and the 
possible risk of severe hypoglycemia may be detrimental and do not result in a reduction 
of cardiovascular risk (ACCORD Study Group; Action to Control Cardiovascular Risk in 
Diabetes Study Group; ADVANCE Collaborative Group; Duckworth et al., 2009; 
Zoungas et al., 2010). Additionally, a review by Fullerton et al. notes studies that have 
found a benefit in intensive glycemic control in reducing the risk of diabetic 
microvascular complications have been of younger patients at earlier stages of the disease 
(2014). These findings highlight the fact that even tight control of glycemia does not 
guarantee freedom from the complications of diabetes and suggest that research into 
strategies that block the adverse effects of hyperglycemia are warranted (Ramasamy, 
2011). Given the high rate of prediabetes and undiagnosed diabetes, as well as the 
number of people who are older and have had the disease longer, new approaches that 
stop or reverse the complications of diabetes are greatly needed. 
Treatment can only benefit those who know they have diabetes. Early detection is 
key to preventing acute and chronic complications. However, hyperglycemia is typically 
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asymptomatic, and diabetes may not even be diagnosed until complications occur, at 
which point serious damage to micro- and macrovascular tissue may already have 
occurred (American Diabetes Association, 2014; International Diabetes Foundation, 
2013). It is estimated nearly one-fourth of the total United States population have 
undiagnosed diabetes (American Diabetes Association, 2014). With this great number of 
individuals unaware of what damage may be taking place in their bodies, it is imperative 
that additional treatment options be investigated to treat the complications of diabetes in 
cases where it was not prevented or diagnosed and treated early. Prevention is the best 
course of action, but given the growing number of diagnosed and undiagnosed cases of 
diabetes, it is necessary to elucidate treatments that can help those who are already 
afflicted with this disease. 
II. Protein Glycation in Diabetes 
Hypotheses to explain vascular complications of diabetes. It is clear that 
hyperglycemia causes microvascular and macrovascular complications. There is much 
research into the exact mechanisms responsible for the damage to vasculature and tissues 
of those with diabetes. Several hypotheses have been developed and continue to be 
researched. Four of these hypotheses include increased polyol pathway flux, activation of 
PKC isoforms, increased flux of the hexosamine pathway and increased advanced 
glycation end-product (AGE) formation (Brownlee, 2001).  
The polyol pathway is the pathway in which glucose is reduced to sorbitol and 
converted to fructose (Lorenzi, 2007). In non-diabetic patients, the use of this pathway to 
metabolize glucose is small. However, during hyperglycemia, increased levels of glucose 
can trigger increased enzymatic conversion of glucose to sorbitol, resulting in greater flux 
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of the pathway; this leads to greater amounts of sorbitol, which does not easily diffuse 
across cell membranes and can damage microvascular cells (Brownlee, 2001; Lorenzi, 
2007). Increased flux through this pathway is thought to lead to increased formation of 
methylglyoxal (a precursor to AGE) and diacylglycerol (DAG) (Brownlee, 2001). It is 
also hypothesized increased amounts of sorbitol can lead to the overexpression of aldose 
reductase, the rate-limiting enzyme in the polyol pathway (Lorenzi, 2007; Brownlee, 
2001). Studies that have inhibited the polyol pathway in order to prevent diabetic 
complications have shown inconsistent results; a study in dogs showed aldose reductase 
inhibition prevented diabetic neuropathy but did not prevent retinopathy or basement 
membrane thickening in the retina, kidney or muscle (Engerman, Kern & Larson, 1994). 
It may be that this pathway is more important in some species than others, and some have 
questioned its relevance in humans in regards to the development of diabetic 
complications (Brownlee, 2001).  
The activation PKC isoforms by DAG is one of the most studied pathways related 
to the pathology of hyperglycemia (Geraldes, 2010). PKC is important in many cellular 
functions and signal transduction pathways (Geraldes, 2010). In hyperglycemia, DAG 
synthesis is increased during glycolysis; DAG can also be indirectly elevated through 
increased activity of the polyol pathway and through ligation of AGE receptors 
(Brownlee, 2001). DAG increases activation of several PKC isoforms, which can lead to 
retinal and renal blood flow abnormalities and may also decrease production of nitric 
oxide in the kidneys (Geraldes, 2010, Brownlee, 2001). In addition, PKC isoforms altered 
by diabetes cause endothelial dysfunction, vascular permeability, changes in vessel 
dilation and basement membrane thickening (Geraldes, 2010). Thus the DAG-PKC 
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pathway is involved in the development of both the microvascular and macrovascular 
pathologies found in diabetes.  
In a state of hyperglycemia, excess glucose may be shunted into the hexosamine 
pathway (HSP). The HSP normally has a small role in the metabolism of glucose, but 
during hyperglycemia, its use is increased, which is hypothesized to contribute to the 
development of insulin resistance and vascular complications associated with diabetes 
(Brownlee, 2001; Buse, 2006). It is also thought that hyperglycemia-mediated increase in 
flux through the HSP facilitates changes in gene expression and protein function, 
although the exact mechanisms are unclear (Brownlee, 2001).  
Protein glycation and formation of AGEs. Another important area of research into 
the mechanisms responsible for the microvascular and macrovascular complications of 
diabetes is protein glycation and AGE formation. Among other targets, proteins in blood 
plasma are susceptible to glycation. The glycation reaction was first described by a 
French biochemist named Louis Maillard, who observed a browning reaction when 
heating glycine with glucose (Maillard, 1912; Simm, 2015). When plasma glucose 
concentrations are high, sugars can bind non-enzymatically to plasma proteins, such as 
albumin and hemoglobin. It should be noted that glycation differs from glycosylation, 
which is an enzymatic reaction (Gkogkolou & Bohm, 2012).  
Glycation of proteins can lead to the formation of AGEs. Non-enzymatic 
glycation occurs when the aldehyde or ketone group of a reducing sugar binds to a free 
amino acid group of a protein, commonly a lysine residue, which forms a Schiff’s base 
(Basta, 2004). The Schiff’s base reaction is reversible but may undergo further 
rearrangements to form a ketoamine called an Amadori product (Basta, 2004; Simm, 
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2015). The resulting Amadori product is still reversible, but is more stable, than the 
Schiff’s base. Amadori products can form highly reactive carbonyl compounds such as 3-
deoxy-glucosone, glyoxal and methylglyoxal, which react with free amino acid groups to 
form intermediate glycation products (Basta, 2004). These intermediate products then 
undergo a slow, complex, irreversible series of reactions to form AGEs (Basta, 2004; 
Simm, 2015). AGEs accumulate in tissues and because of their stability, levels do not 
decrease even after hyperglycemia is corrected (Makita et al., 1991).  
 
Fig. 1 The formation of advanced glycation end products (AGEs). Adapted from 
Kawahito, Kitahata & Oshita, 2009 
 
Non-diabetic patients have very low levels of protein glycation, however, diabetic 
patients have much higher rates of glycation (Austin et al., 1987) as AGEs form more 
rapidly during chronic hyperglycemia (Ramasamy, 2011). The rates of glycation differ 
between plasma proteins; this difference is thought to be due to the length of biological 
half-lives and susceptibility of each protein to glycation (Austin et al., 1987). Proteins 
such as albumin and immunoglobulins, which have the longest half-lives, show the 
greatest rate of glycation (Austin et al., 1987). 
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Albumin is the most abundant protein in human plasma and has several important 
physiological functions. Made in the liver, 50% - 60% of total plasma protein is 
comprised of albumin (Kim & Lee, 2012). This protein plays a role in fluid balance 
between body compartments, transport of hormones, fatty acids, and metabolites in the 
blood, regulation of the oncotic pressure of plasma, and is also known to behave as an 
antioxidant (Kim & Lee, 2012; Rondeau & Bourdon, 2011). In regards to its antioxidant 
capacity, albumin is responsible for the majority of free radical trapping and may protect 
other proteins from glycation during the initial onset of diabetes by limiting oxidative 
damage (Kim & Lee, 2012; Rondeau & Bourdon, 2011). Albumin is susceptible to 
glycation due to its long half-life and sheer abundance in the plasma; in healthy 
individuals glycated albumin is between 1% - 10% (Shaklai, Garlick & Bunn, 1984), 
while in diabetic individuals it is increased two to three times this amount (Rondeau & 
Bourdon, 2011) with some levels reaching greater than 90% in diabetics with poor 
glucose control (Kisugi et al., 2007).  
Glycation modifies the tertiary structure of albumin and increases its molecular 
weight which impairs its function (Shaklai, Garlick & Bunn, 1984). Albumin is primarily 
glycated at the lysine-525 residue with several other lysine residues also susceptible to 
glycation (Garlick & Mazer, 1983). Glycated albumin is directly associated with ROS 
production, which spurs oxidation and accelerates the production of AGEs (Kim & Lee, 
2012). Some in vivo studies have shown inhibition of albumin glycation can help prevent 
the progression of diabetic complications (Rondeau & Bourdon, 2011).  
Another plasma protein susceptible to glycation is hemoglobin. This component 
of erythrocytes was the first glycated protein to be discovered and its measurement is 
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widely used as a tool to monitor glycemic control (Gkogkolou & Bohm, 2012; Kim & 
Lee, 2012). There are several different fractions that make up the group of hemoglobins 
which together are known as HbA1, with the most glycated hemoglobin being HbA1c 
(Kilpatrick, 2000). Hemoglobin is glycated at the N-terminal valine and internal lysine 
amino groups; due to the relative stability of this glycation reaction and the average 
lifespan of erythrocytes (120 days), the measurement of HbA1c can indicate the level of 
glycemic control over the last 8-12 weeks (Simm, 2015; Soranzo, 2011).  
Both glycated albumin and glycated hemoglobin have been described in detail 
due to their utility in monitoring and assessing plasma glucose control in individuals with 
diabetes. While using HbA1c to monitor glycemic status and control has been the most 
widely used method, some have suggested the measurement of glycated albumin may 
also be useful, especially in individuals with anemia, impaired renal function and 
gestational diabetes (Kim & Lee, 2012; Rondeau & Bourdon, 2011). Due to the shorter 
half-life of albumin, glycated albumin measurements could provide useful information 
about glucose control and treatment effectiveness over a more recent time period, about 
2-4 weeks (Rondeau & Bourdon, 2011).  
It should be noted while there is research into these four different hypotheses of 
mechanisms that lead to microvascular and macrovascular damage due to hyperglycemia, 
they are not separate entities. Each is related; increased flux of the polyol pathway can 
lead to production of methylglyoxal, an AGE precursor, and DAG, which activates PKC 
(Brownlee, 2001). Ligation of AGE receptors can also indirectly activate PKC isoforms 
(Brownlee, 2001). Some have speculated there is a common element linking these four 
mechanisms; all processes are induced by an overproduction of superoxide by the 
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mitochondrial electron-transport chain caused by hyperglycemia (Brownlee, 2001). If this 
is the case, it is suggested that interrupting the overproduction of superoxide could 
possibly normalize the mechanisms discussed (Brownlee, 2001).  
Pathological effects of AGEs. AGEs are thought to contribute to many major 
diseases and disorders including insulin resistance, diabetes and its complications, kidney 
disease, cardiovascular disease, Alzheimer’s disease, Parkinson’s disease, cataracts, 
autoimmune diseases and endocrine disorders (Korwar et al., 2015; Manigrasso et al., 
2014; Ottum & Mistry, 2015; Simm et al., 2015). Formation of AGEs is a normal part of 
metabolism, and levels increase with age. However, defense systems have evolved that 
maintain AGE homeostasis in healthy animals, including endogenous and exogenous 
antioxidant systems, enzymatic degradation, clearance in the kidneys and receptor-
mediated cell uptake and degradation (Ottum & Mistry, 2015). During a state of 
hyperglycemia, these defense systems are overrun and the process of glycation and 
formation of AGEs are accelerated (Kellow et al., 2014). In addition to hyperglycemia, 
formation of AGEs is promoted by oxidative stress, sedentary lifestyles, smoking and 
diets high in fat, AGEs, and excess calories (Alam, Ahmed & Naseem, 2015; Kellow et 
al., 2014; Korwar, 2015; Ottum & Mistry, 2015). Once AGEs are formed and begin to 
accumulate in the body, they exert pathological effects which are thought to contribute to 
the complications associated with diabetes, as well as insulin resistance thereby leading 
to the pathogenesis of type 2 diabetes (Korwar, 2015; Ramasamy 2011). In diabetic rats, 
AGEs accumulate at sites where known diabetic vascular damage occurs - retinas, renal 
glomeruli and peripheral nerves (Berlanga et al., 2005). Diabetics have substantially 
higher levels of AGEs in the plasma as compared to nondiabetic individuals (Korwar, 
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2015). AGEs build up in extracellular spaces and within vessel cell walls and they have a 
distinctive yellow-brown color and produce reactive oxygen species (ROS) (Brownlee, 
Cerami & Vlassara, 1988). ROS created by AGEs promote production of more AGEs 
thus beginning a destructive cycle (Farmer & Kennedy, 2009). AGEs are composed of a 
large number of different chemical structures with N-q-carboxy-methyl-lysine (CML) as 
the predominant type of AGE that accumulates in humans (Reddy et al., 1995).  
There are several ways in which AGEs cause pathological damage. One important 
pathway in the pathogenesis of diabetes is the receptor-mediated AGE-RAGE interaction. 
RAGE is a molecule belonging to the immunoglobulin superfamily that has multiple 
ligands, including AGEs, and is implicated in causing oxidative stress and activating pro-
inflammatory pathways (Basta, 2004; Ramasamy, 2011). Thus, it is via RAGE that AGEs 
can activate signal transduction cascades and mechanisms that cause cell stress, 
dysfunction, damage and changes in gene expression to specific organ tissues 
(Ramasamy, 2011). Under normal conditions, RAGE appears to be important in AGE 
degradation and as a defense against infection, injury or inflammation (Basta, 2004; 
Ramasamy, 2011). However, when AGEs, as well as other pro-inflammatory ligands, 
accumulate in the body, they promote increased RAGE expression, which in turn 
increases oxidative stress and the activation of the signal transduction cascades 
mentioned, thus promoting the development of chronic disease (Ramasamy, 2011).  
Atherosclerosis is a major vascular complication of diabetes. The vascular 
endothelium is important in regulating vessel permeability, blood flow and vessel tone 
(Basta, 2004). During chronic hyperglycemia, and the resulting formation of AGEs, the 
endothelium is exposed to AGEs, which bind to RAGE, and cause increased permeability 
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and transit of macromolecules through the endothelium (Esposito et al., 1989). The AGE-
RAGE interaction also depletes antioxidants, such as glutathione and Vitamin C 
(Bierhaus et al., 1997), which in turn further promotes the generation of ROS (Yan et al., 
1994). AGEs also interfere with the bioavailability of the important vasodilator nitric 
oxide (Bucala, Tracey & Cerami, 1991) and promote the expression of powerful 
vasoconstrictors, thus disrupting endothelial control of vascular tone (Quehenberger, 
2000). Experimental evidence also suggests AGEs cause the release of inflammatory 
cytokines and growth factors and promote adhesion molecules on vascular cells (Basta, 
2004). The combined effect of increased permeability, loss of vascular tone control, 
release of pro-inflammatory molecules, and an increase in adhesion molecules in vascular 
cells triggers chronic vascular inflammation and an ongoing cycle of cell damage and 
dysfunction, aided by the release of inflammatory peptides and other ligands of RAGE 
(Basta, 2004). Chang et al. found that levels of AGEs are positively correlated with lipid 
profiles and atherosclerotic characteristics; in fact, their research found subjects with 
higher AGEs levels had higher total cholesterol, triglycerides, LDL-C and lower HDL-C 
and that levels of circulating AGEs may be a better indicator of atherosclerotic lesions 
than either fasting plasma glucose or HgA1c (2011).  
As mentioned, AGE-mediated RAGE activation has also been implicated in the 
microvascular complications of diabetes. The same processes described for vascular 
damage occur at the microvascular level. In the development of retinopathy, 
concentrations of RAGE in the retina are increased (Barile, 2005). RAGE is thought to 
regulate several pathophysiological responses by Müller glia cells in the retina in 
response to stress caused by diabetic conditions (Zong, 2010). Müller glia cells are 
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activated by RAGE and promote the downstream production of cytokines, which 
contribute to inflammation (Zong, 2010).  
AGEs have been implicated in the pathogenesis of diabetic nephropathy (Bolton 
et al., 2004) and neuropathy (Bierhaus, 2004). Both AGEs and RAGE are found in higher 
amounts in the kidneys of diabetics as compared to non-diabetics, with a greater 
accumulation in the glomerulus, both in the podocytes and the endothelial cells (Tanji et 
al., 2000). In diabetics, a high level of AGEs, especially CML, have been found in the 
peripheral nerves (Bierhaus, 2004). Moreover, Bierhaus et al. found greater RAGE 
expression in cells near AGE accumulation in peripheral nerves of diabetics with 
neuropathy (2004).  
Therapies to prevent, reduce or degrade AGEs. Several possible strategies have 
emerged and are being researched to prevent, reduce or break down AGEs. These 
strategies include drugs that prevent AGE formation such aminoguanidine and 
pyridoxamine. Aminoguanidine showed promise in animal studies by trapping early 
glycation products, however, human trials were halted after adverse effects were 
experienced by subjects (Bolton et al., 2004). Some research suggests calorie restriction 
may reduce levels of AGEs, most likely by reducing the amount of dietary AGEs 
(dAGEs) consumed (Vlassara & Striker, 2013). Lastly, nutraceuticals, vitamins, minerals 
and other nutrients, are being investigated for their antioxidant properties; these 
compounds may help limit AGE formation by decreasing oxidation that spurs further 
AGE formation and oxidative damage (Gkogkolou & Bohm, 2012). Some of these 
antioxidants include ascorbic acid (vitamin C), α-tocopherol, niacinamide and zinc, 
which have been shown to prevent glycation of albumin in vitro (Gkogkolou & Bohm, 
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2012, Tupe et al., 2015). Vitamin C supplementation greatly reduced protein glycation in 
non-diabetic individuals (Davie, Gould & Yudkin, 1992; Vinson & Howard, 1996). 
Given that AGEs are an important pathogenic factor in the development of diabetes, 
continued research is needed to discover ways to reduce or break down AGEs in the 
body. As highlighted earlier, many individuals are unaware they have diabetes and thus 
incur damage caused by hyperglycemia and accumulation of AGEs. Prevention of 
diabetes is the best course of action, however, when diabetes has developed and treatment 
is needed, strategies to reduce the microvascular and macrovascular damage that leads to 
diabetic complications is of utmost importance. 
III. Birds as Models of Diabetes 
Animal models of diabetes. To fully understand the role of hyperglycemia and 
protein glycation in the pathogenesis of the complications of diabetes, appropriate animal 
models are needed. Due to the slow progression of the disease, in which it can take years 
for symptoms of complications to manifest, conventional animal models, such as short-
lived mice and rats, do not provide data that is comparable to humans (Szwergold & 
Miller, 2013). Even longer-lived animals, such as monkeys and pigs, can pose logistical 
research problems, making long-term study both difficult and expensive (Szwergold & 
Miller, 2013). In either case, hyperglycemia has to be induced or inbred, which results in 
sick animals that are difficult to maintain and care for (Szwergold & Miller, 2013). In 
light of these difficulties, another model has been suggested that eliminates many of these 
problems - birds. 
While in the past birds have been used to study the process of aging, because of 
certain biochemical characteristics, it has been proposed birds would also provide a 
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useful model of diabetes (Szwergold & Miller, 2013). Birds naturally have high plasma 
glucose levels (Beuchat & Chong, 1998; Braun & Sweazea, 2008) and generally have 
low sensitivity to insulin-mediated glucose uptake (Shiraishi et al., 2011; Sweazea & 
Braun, 2005; Sweazea, McMurtry & Braun, 2006), however, birds do not suffer the same 
pathologies of hyperglycemia and insulin resistance that mammals do as the high glucose 
concentrations are a normal aspect of their physiology. Thus it is apparent birds may 
possess defense mechanisms that protect them from their naturally high circulating 
glucose and this is evidenced by the fact that birds outlive mammals of comparable body 
size by up to three times (Braun & Sweazea, 2008; Holmes, et al., 2001). Birds are 
healthy and pathology-free, despite sustained naturally high plasma glucose levels, and 
show that it is possible to live with high glucose concentrations and not develop 
complications. Discovering what protects birds from the deleterious consequences of 
high plasma glucose concentrations would aid in creating new approaches to preventing 
and treating diabetes and its related complications in humans.  
Variations in glucose homeostasis between birds and mammals. Understanding 
the differences in physiology and biochemical mechanistic function between birds and 
mammals is important in determining what mechanisms protect birds from the effects of 
maintaining high plasma glucose concentrations. Carbohydrate metabolism is of interest 
when studying birds as models of diabetes. Some research has shown that birds 
preferentially use fatty acids as an energy source for flight (Jenni & Jenni-Eiermann, 
1998), however, despite this, they maintain high levels of plasma glucose compared to 
mammals of similar body size (see review: Braun & Sweazea, 2008; figure 2). Healthy 
birds maintain plasma glucose concentrations of 150 mg/dL or more, with some birds, 
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such as hummingbirds, maintaining levels as high as 800 mg/dL (Beuchat & Chong, 
1998; Harr, 2002).  
 
Fig. 2 The relationship between plasma glucose concentrations and log body mass (LBM 
in kg) for birds (n=97) and mammals (n=162). Data were extracted from the International 
Species Information System (ISIS), Physiological Data Reference Values 2002. Adapted 
from Braun & Sweazea, 2008 (J. Zuck thesis, 2015) 
 
The same carbohydrate metabolic pathways that operate in mammals also appear 
to operate in birds (Pollock, 2002). Glucose is derived from the metabolism of ingested 
carbohydrates and is used by birds for many purposes, mainly for the production of 
energy through oxidation, glycogen and fatty acid synthesis, the synthesis of other 
important metabolites, such as amino acids and vitamin C, and to fuel take-off and short 
flights (Braun & Sweazea, 2008). Glucose is absorbed either by carrier-mediated 
transport into and out of enterocytes and/or by passive diffusion through intercellular 
spaces between enterocytes (Braun & Sweazea, 2008; Pollock, 2002). For many avian 
species, passive diffusion may be the more important pathway for glucose absorption 
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since the cost of energy is low. In fact, birds such as nectar-eating lorikeets, yellow-
rumped warblers and house sparrows predominantly absorb glucose by passive diffusion 
(Afik, McWilliams & Karasov, 1997; Karasov & Cork, 1994). Carrier-mediated 
absorption, in contrast, uses adenosine triphosphate (ATP) to power transport proteins 
(Braun & Sweazea, 2008). Regardless of absorption pathway, once it is absorbed, glucose 
can be metabolized through glycolysis and lead to the synthesis of ATP; one molecule of 
glucose yields 38 molecules of ATP (Pollock, 2002). Also, approximately one-third of 
the glucose absorbed is converted to lactate, an important precursor for gluconeogenesis 
(Riesenfeld et al., 1982). Interestingly, glucose absorption of birds matches the amount of 
glucose in the diet; for example, the nectarivorous Rufous hummingbird has a glucose 
uptake that is 15 times greater than an omnivorous chicken and 50 times greater than a 
carnivorous loggerhead shrike (Pollock, 2002).  
In mammals, once glucose is absorbed and in circulation, uptake into cells is 
important in maintaining glucose homeostasis. Glucose is an essential energy source for 
all cells in animals and it is transported into cells by facilitated diffusion across plasma 
membranes, a process mediated by glucose transporter proteins (GLUTs) (Suzuki & 
Kono, 1980). 12 tissue-specific GLUT isoforms (GLUT 1-12) have been identified in 
mammals (Carayannopoulos et al., 2000; Doege et al., 2001; Gould and Holman, 1993; 
McVie-Wylie et al., 2001; Phay et al., 2000; Rogers et al., 2002). The isoform GLUT-4 is 
a major component of insulin-stimulated glucose uptake into skeletal muscle and adipose 
tissues in mammals (Kern et al., 1990). Much of the research into GLUT transport 
proteins has come from work with mammal models, therefore less is known about how 
glucose enters cells in birds (Sweazea & Braun, 2005). Currently, only four GLUT 
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isoforms similar to human GLUTs have been identified in birds (GLUT 1-3, 8); insulin-
specific glucose transport proteins, such as GLUT-4, have not been identified in birds 
(Seki et al., 2003; Sweazea & Braun, 2006).  
Skeletal muscle plays an important role in glucose homeostasis in mammals. 
GLUT-4 is expressed in this tissue and is estimated to clear 70-75% of postprandial 
glucose from the blood (Sweazea & Braun, 2005; Tokushima et al., 2005). Due to the 
high plasma glucose levels observed, it has been questioned whether or not an insulin-
responsive transporter like GLUT-4 is present in bird skeletal muscle. Few studies have 
addressed this question. Seki et al. looked to identify GLUT-4 expression in tissues from 
broiler chickens; GLUT-4 was not detected and no GLUT-4 homolog could be identified 
(2003). Sweazea and Braun likewise found no GLUT-4 gene or expression in skeletal and 
cardiac muscle from English sparrows (2005). Tokushima et al. note that a GLUT-4-like 
gene sequence has not been found in either chicken expressed sequence tag (EST) or 
genome databases (2005). In the absence of a GLUT-4-like transporter, some have 
questioned if an alternative insulin-responsive transporter exists in birds (Seki et al., 
2003; Tokushima, 2005). The isoform GLUT-8 has been shown to be insulin-responsive 
and expressed in various tissues such as the heart, kidney, brain, muscle and liver (Seki et 
al., 2003). Seki et al. found that GLUT-8 was expressed highly in chicken kidney and 
moderately in the brain, adrenal, spleen, lung and pancreas, but it was barely detectable in 
the liver, skeletal muscles, adipose tissue or heart (2003). It is hypothesized the lack of a 
GLUT-4-like transporter, and to a lesser extent, the low expression of GLUT-8, in part 
contributes to the hyperglycemia and resistance to insulin-mediated glucose uptake 
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observed in birds (Seki et al., 2003; Sweazea & Braun, 2005; Sweazea, McMurtry & 
Braun, 2006).  
The most distinct difference in carbohydrate metabolism between mammals and 
birds is in the hormonal control of glucose (Pollock, 2002). Instead of the hypothesis that 
GLUT-4 is a contributing factor to hyperglycemia and insulin resistance, it might be 
more accurate to say that in order to maintain high levels of plasma glucose and insulin 
insensitivity, GLUT-4 is not expressed in birds (Sweazea & Braun, 2005). High glucose 
concentrations and insulin resistance are the hallmarks of type 2 diabetes in humans but 
appear to be normal for birds. Insulin is the dominant pancreatic hormone in mammals, 
however, this is not the case in birds, although there are interspecies variations in 
hormonal control (Pollock, 2002). In the fed state, the hormone insulin is responsible for 
lowering blood glucose levels by increasing the number of glucose transport carriers and 
by binding to insulin receptors on cells to signal the translocation of glucose transport 
proteins from intercellular spaces to the cell wall (Shepard & Kahn, 1999; Suzuki & 
Kono, 1980). Any defect in this pathway can lead to insulin resistance and result in 
hyperglycemia.  
Insulin is an anabolic hormone and drives fuel storage, as either glycogen or fat 
(Hickey et al., 2011) and suppresses gluconeogenesis, glycogenolysis and lipolysis. 
Glucose is the trigger for insulin release in mammals, however, it is not the main trigger 
for insulin release in birds; even when released, birds are generally resistant to the effects 
of insulin as high concentrations are required to stimulate glucose uptake into cells 
(Hazelwood, 1973; Sweazea & Braun, 2005; Tokushima et al., 2005). Interestingly, 
despite having higher concentrations of plasma glucose, birds maintain plasma insulin 
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levels comparable to mammals (Simon, 1989). The resistance to insulin observed in birds 
may have to do with the fact that free fatty acids are preferentially used for energy during 
flight; using fatty acids may inhibit the insulin-signaling pathway and may also down-
regulate insulin receptors (Jenni & Jenni-Eiermann, 1998). A study by Kuzmiak et al. 
showed a preference for fatty acid oxidation even at the level of isolated mitochondria 
from the pectoralis muscles of house sparrows (2012). While in mammals lipolysis is 
inhibited by insulin, in birds insulin does not suppress lipolysis (Pollock, 2002). Thus, the 
need for birds to power and sustain long flights with fatty acids may explain the relative 
resistance to insulin and an apparent greater sensitivity to glucagon found in birds 
(Hickey et al., 2011).  
Glucagon is the counter-regulatory hormone of insulin. While birds show 
resistance to insulin and its effects, they show greater sensitivity to glucagon than 
mammals (Hazelwood, 1973). This hormone is catabolic, and as such, stimulates 
glycogenolysis, gluconeogenesis and lipolysis to release glucose, triglycerides, glycerol 
and free fatty acids into the blood to be used as substrates for energy several hours 
postprandial or in a fasting state (Braun & Sweazea, 2008; Pollock, 2002). Glucagon 
appears to be the dominant pancreatic hormone that maintains metabolic homeostasis in 
birds, with as much as 10 to 80 times more glucagon circulating as compared to 
mammals (Hazelwood, 1989; Pollack, 2002). This physiological difference can be traced 
back to the islets of Langerhans in the pancreas; in birds, there are a greater number of 
alpha cells, which secrete glucagon, than there are beta cells, which secrete insulin 
(Ruffier, Simon & Rideau, 1998). As in mammals, glucose inhibits the release of 
glucagon in birds (Ruffier, Simon & Rideau, 1998). While in mammals the ratio between 
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insulin and glucagon seeks to balance anabolic and catabolic phases, in birds this ratio 
tends to favor catabolism for an ever ready supply of energy to fuel a high metabolism; 
the normal insulin/glucagon ratio is 1 to 2 or lower (Karasov & Cork, 1994; Karasov & 
Levey, 1990). 
When more glucose is consumed than is immediately needed, excess glucose is 
converted to and stored as glycogen in the liver and muscles. Glucagon triggers the 
conversion of glycogen back into glucose when needed (Pollock, 2002). Liver glycogen 
is utilized during short-term fasts to provide glucose to the brain and other organs that 
preferentially utilize glucose (Pollock, 2002). In birds, glycogen stored in muscle remains 
relatively stable during short-term fasts, however, glycogen levels decrease greatly during 
prolonged fasts, especially in carnivorous birds (Pollock, 2002). On the whole, birds store 
less glycogen in muscle than do mammals, which given the high levels of plasma glucose 
in birds means glucose stays in the blood instead of being converted to glycogen (Braun 
& Sweazea, 2008; Hickey et al., 2011). Glycogen release appears to be activity-
dependent, depending on the degree of activity and the species, glycogen stores can be 
used up within 15-30 minutes to a few hours (Pollock, 2002). However, in birds, 
glycogen is of little importance during long bouts of flying, which is fueled by fatty acids 
(Jenni & Jenni-Eiermann, 1998). A unique feature among birds as compared to mammals 
and other vertebrates is the presence of a glycogen body in the lumbosacral region 
(Moller & Kummer, 2003). It is thought this tissue forms glycogen taken up by GLUT-1, 
however, the stimulus of release of glycogen from the glycogen body has not yet been 
determined and the function and purpose of this tissue is still not understood (Braun & 
Sweazea, 2008).  
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In most birds, gluconeogenesis begins several hours after eating due to low 
glycogen stores coupled with the demands of high metabolic rates (Braun & Sweazea, 
2008; Pollock, 2002). The process occurs mostly in the liver and somewhat in the kidney; 
the primary substrates for gluconeogenesis are glycerol and lactate (Hazelwood & 
Lorenz, 1959; Klasing 1998; Pollock 2002). In birds, gluconeogenesis works to maintain 
plasma glucose concentrations at a constant level despite feeding frequency or dietary 
intake; more than 70-75% of glucose in circulation is produced by gluconeogenesis and 
released from the liver (Braun & Sweazea, 2008; Pollock 2002). In fact, after several 
days of fasting, plasma glucose concentrations will rise to normal levels due to 
gluconeogenesis (Pollock, 2002). A remarkable example of this is found in male emperor 
penguins; after a 115 day breeding fast, no significant alterations in plasma glucose levels 
are observed (Groscolas, 1986).  
Several avian organs have notable differences compared to mammals in regards to 
glucose homeostasis. As just described, the liver plays a major role in maintaining the 
high levels of plasma glucose concentrations observed in birds at a constant level. The 
liver accomplishes this task by being the site of glycogenolysis and gluconeogenesis, 
which contribute a majority of the circulating glucose (Braun & Sweazea, 2008). 
Notably, some bird species have lower numbers of insulin receptors in the liver (Rideau, 
1998), which invariably contributes to insulin resistance and further contributes to their 
naturally high plasma glucose levels.  
In mammals, the pancreas performs an important role in glucose homeostasis. 
Pancreatic activity in birds differs somewhat from its mammalian counterpart. As noted, 
in birds the pancreas has fewer beta cells and more alpha cells, which means more 
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glucagon is produced and secreted than insulin (Ruffier, Simon & Rideau, 1998). 
Granivorous birds, such as chickens, have about 1/6 the amount of insulin in the pancreas 
as compared to mammals, while glucagon levels are two to three times higher (Harr, 
2002). Glucose is required in large doses to stimulate insulin release and in fact, when the 
beta cells of the avian pancreas are chemically destroyed, no significant effect on plasma 
glucose is observed (Stellenwerf & Hazelwood, 1979). A similar action in mammals 
leads to hyperglycemia and ultimately diabetes. Of interest, removing the pancreas from 
some bird species does not result in the development of diabetes (Hazelwood, 1989). In 
fact, after pancreatectomy, transient hyperglycemia may result, but plasma glucose levels 
return to normal after a short amount of time (one week in white domestic ducks) 
(Koppanyi et al., 1926). The ability of birds to maintain plasma glucose levels after 
pancreatectomy suggests that an extra-pancreatic source of both insulin and glucagon 
may exist (Colca & Hazelwood, 1976).  
The kidneys are another organ system that functions to maintain glucose 
homeostasis in birds. What is interesting about the kidneys is that although birds have 
very high plasma glucose, no glucose is lost in the urine (Morgan & Braun, 2001). Avian 
nephrons effectively filter and reabsorb glucose before excretion so that no glucose 
appears in the urine (Lotz & Martinez del Rio, 2004), in contrast to mammalian kidneys 
which have a glucose absorption threshold (Gorden, 1997). This suggests that all glucose 
consumed and absorbed by the intestines and also made through gluconeogenesis is 
utilized by birds (Braun & Sweazea, 2008).  
What might be the physiological advantage for birds to have high plasma glucose 
levels and insulin resistance, as has been discussed? Several benefits have been 
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hypothesized. As noted, birds store less glucose as glycogen and rather use the blood for 
a kind of reserve of readily available glucose, which may help supply the demands of 
high metabolic rates (Hickey et al., 2011). Also, glycogen, when stored in muscle, is 
hygroscopic, meaning it attracts and stores two and a half to three times its weight in 
water which makes glycogen heavy and not the best fuel storage method for birds that 
engage in flight and migration, where excess weight is not ideal (Hickey et al., 2011; 
Kuzmiak et al., 2012). Less glycogen stored in muscle means there is more room for 
mitochondria to help power flight and less weight to carry (Hickey et al., 2011). The 
insulin to glucagon ratio observed in birds tends to favor gluconeogenesis and lipolysis 
which makes fuel constantly available to not only sustain the higher rate of metabolism 
observed in birds but to supply adequate fuel for flight and other metabolically stressful 
activities such as egg laying and fasting during molting (Pollock, 2002). In addition, 
insulin resistance may protect tissues from oxidative damage that may occur when too 
much glucose is taken up by cells during hyperglycemia (Sweazea & Braun, 2005).  
 Protein glycation and AGEs in birds. In mammals, glycation of proteins in the 
presence of chronic hyperglycemia and subsequent formation of AGEs leads to the 
development of microvascular and macrovascular pathologies associated with diabetes. 
Given that birds have higher metabolic rates, body temperatures and levels of plasma 
glucose in general as compared to mammals, it would be expected that birds also have 
higher levels of protein glycation and AGEs. However, available evidence suggests birds 
generally have lower rates of protein glycation and AGE formation despite these 
conditions (Holmes, Fluckiger, & Austad, 2001; Iqbal et al., 1999; Kita, 2011; Machin et 
al., 2003). There is little research into protein glycation in birds, however, some specific 
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glycation products have been studied; pentosidine, glycated hemoglobin and glycated 
albumin. 
 Pentosidine is an AGE that is formed by glycation of collagen, a structural 
protein, and has been used as a biomarker for aging since it increases in tissues with 
advancing age (Iqbal et al. 1999; Vleck, Haussmann & Vleck, 2007). Iqbal et al. found 
despite high levels of plasma glucose, pentosidine content in the skin of chickens was 
markedly lower than what is observed in mammals (Iqbal, 1999). It is not clear why this 
is the case. One hypothesis is the collagen structure differs between mammals and birds 
and thus may inhibit non-enzymatic glucose binding or pentosidine formation may be 
prevented by high levels of uric acid, a powerful antioxidant, that inhibits oxidative steps 
in the AGE formation process (Klandorf & Iqbal, 1999). Gu et al. also found chickens 
had 2.3 times lower pentosidine concentrations than humans, which suggests that high 
plasma glucose levels do not lead to greater AGE formation in chickens as is observed in 
diabetic humans (2012).  
 Among birds, hummingbirds have the highest plasma glucose levels (>650 
mg/dL), yet have remarkably low levels of glycated hemoglobin, in the range of 2-5% 
(Beuchat & Chong, 1998). While this range is high among birds, it is not problematic in 
mammals. Duck, chicken and turkey glycated hemoglobin levels have been measured in 
the range of 0.5-1.0% (Rendell et al., 1985). One explanation for this occurrence involves 
structural differences in erythrocytes between mammals and birds. Mammalian 
erythrocytes lack a nucleus and are fairly permeable to glucose, while bird erythrocytes 
are nucleated and are less glucose permeable (Beuchat & Chong, 1998; Holmes, 
Fluckiger, & Austad, 2001). Another factor may be erythrocyte lifespan; bird 
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erythrocytes have half-lives of 50-70% of mammalian erythrocytes (Beuchat & Chong, 
1998; Holmes, Fluckiger, & Austad, 2001). Lower glucose permeability and shorter 
lifespans of avian erythrocytes mean glycated hemoglobin is more quickly replaced 
(Hickey et al., 2011).  
Interestingly, some research shows the glycation of albumin is comparable 
between chickens and mammals (Rendell et al., 1985), however, despite this, birds in 
general exhibit lower overall levels of AGEs than mammals (Holmes, Fluckiger, & 
Austad, 2001). Rendell et al. measured levels of glycated hemoglobin and albumin in 
several species of mammals and birds and found chickens had lower levels of glycated 
hemoglobin (0.54%) than humans (5.76%) yet had higher levels of albumin glycation 
(2.35%) compared to humans (1.5%) (1985). In a prior study, Anthony et al. found that 
glycation of avian and bovine albumin appears to be glucose dependent, since rates of 
glycation increased as glucose concentration increased, which supports earlier evidence 
of albumin glycation in birds. In humans, albumin is highly glycated and makes up a 
large part of serum AGEs (Korwar, 2015). Human serum albumin is glycated at surface-
exposed lysine residues (Korwar, 2015). In chickens, the predicted conformational 
structure of albumin differs from mammals with two of the lysine residues available for 
glycation folded inwards and thus not exposed, making nonenzymatic binding more 
difficult (unpublished observations).  
 In mammals, glycated proteins undergo further chemical reactions to become 
AGEs. AGEs accumulate in tissues and levels do not decrease even after hyperglycemia 
is corrected (Makita et al., 1991). Kita examined tissue distribution of AGEs in birds by 
administering radioactive AGEs to chickens and found accumulation was greatest in the 
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liver, kidney and spleen of the birds (2011). This is interesting given that one of the main 
functions of these organs is to clear toxins and metabolic waste from the body; perhaps 
AGEs in chickens are cleared by the liver, kidney and spleen, thus leading to the lower 
levels of AGEs observed (Kita, 2011). Interestingly, AGEs do not accumulate in the eyes 
of chickens suggesting other pathways, such as the polyol pathway, may be more 
important in the pathology of diabetic retinopathy (Kita, 2011). This may in part be due 
to the structural differences of the eye between mammals and birds, namely, birds have 
avascular retinas, while mammalian retinas are vascularized (Chase, 1982; Wolberg et 
al., 1999). Thus, mammalian intra-retinal vasculature is more prone to damage from 
hyperglycemia than avian avascular retinas.  
 Overall, the low rates of protein glycation observed suggest birds have evolved 
and possess adaptations and mechanisms that prevent and/or protect against protein 
glycation and the formation of AGEs (Holmes, Fluckiger, & Austad, 2001; Szwergold & 
Miller, 2014). One such adaptation may involve RAGE. There is little research into 
RAGE in avian species, however, preliminary evidence suggests that RAGE may not be 
present in birds. Researchers found mourning dove tissues lacked RAGE proteins (F. 
Eythrib thesis, 2013). A comparison of DNA sequence data between mammals, rodents 
and birds (chickens, turkeys and zebra finches) found that birds do not possess a homolog 
to mammalian RAGE (Szwergold & Miller, 2014). Shortly after this study was 
published, a second appeared showing that only mammals express RAGE (Sessa et al., 
2014). Lack of RAGE helps explain how birds protect against protein glycation and the 
pathological effects of AGEs. 
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 ROS and oxidative stress. Considerable research has focused on oxidative stress 
and its causes. Oxidative stress results from the formation of highly reactive molecules, 
ROS, namely the superoxide radical, hydroxyl radical and hydrogen peroxide, which in 
excess quantities can damage cells and tissues and lead to the loss of physiological 
function (Vleck, Haussmann & Vleck, 2007). While a chronic excess of ROS can cause 
damage to tissues and is implicated in many disease states, it is important to note ROS 
production is a normal part of cellular metabolism and ROS do serve important 
physiological purposes in maintaining homeostasis in healthy individuals (Finkel & 
Holbrook, 2000). ROS are important in muscle contraction (Ristow et al., 2009), 
signaling pathways in the vasculature and other pathways (Brownlee, 2001) and cellular 
apoptosis (Finkel & Holbrook, 2000). ROS also have an immune system function and 
help to defend against toxins and invading microorganisms (Finkel & Holbrook, 2000). 
Intermittent high ROS production brought on by exercise has been shown to be beneficial 
(Ristow et al., 2009). Mitochondria produce the majority of ROS in animal cells; some 
limited research suggests animals with longer lifespans have lower rates of ROS 
production, suggesting longer-lived animals have defense systems to protect against 
oxidative damage (Barja & Herrero, 2000; Sohal et al., 1989). In fact, in mammals, 
maximum lifespan is inversely related with metabolic rate and rate of ROS production 
(Sohal & Weindruch, 1996).  
 During chronic hyperglycemia in mammals, ROS production (specifically the 
superoxide radical and hydrogen peroxide) and subsequent tissue damage are increased 
(Brownlee, 2001; King & Loeken, 2004). This happens in part because chronically 
elevated levels of plasma glucose cause uncoupling in the electron transport chain which 
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leads to ROS production (Brownlee, 2001). In addition, elevated glucose levels lead to 
the production of AGEs which in turn cause oxidative damage (Yao & Brownlee, 2010). 
The formation of AGEs involves oxidative steps and the interaction of AGEs with their 
receptors, such as RAGE, cause oxidative stress and damage (Yan, Levine & Sohal, 
1997). Both ROS and AGEs cause oxidative damage to tissues and vasculature in 
mammals (King & Loeken, 2004). Hyperglycemia may also down-regulate antioxidant 
systems which protect against ROS (West, 2000).  
 Birds have higher metabolic rates and levels of plasma glucose than mammals, 
which means they should also have higher levels of ROS production and oxidative stress, 
however, this does not seem to be the case. Despite high metabolic rates and high plasma 
glucose, birds live up to three times longer than mammals of comparable body mass 
(Speakman, 2005). As oxidative stress has been implicated in the process of aging 
(Vleck, Haussmann & Vleck, 2007) and the production of AGEs, this suggests bird 
physiology somehow prevents oxidative damage from occurring (Braun & Sweazea, 
2008). Some studies in pigeons have shown resistance to ROS formation in the brain, 
heart and kidney tissues despite high plasma glucose levels (Ku & Sohal, 1993).  
Several processes may be at work to prevent oxidative damage in birds. Some 
evidence shows there may be differences in ROS production between birds and mammals 
in that birds produce lower levels of ROS (Braun & Sweazea, 2008; Iqbal et al., 1999; 
Holmes, Fluckiger, & Austad, 2001; Vleck, Haussmann & Vleck, 2007). Birds also 
appear to have more robust antioxidant systems with higher levels of antioxidants that 
scavenge ROS, such as superoxide dismutase, catalase, glutathione peroxidase and uric 
  46 
acid, which help to make cells more resistant to oxidative stress (Braun & Sweazea, 
2008; Holmes, Fluckiger, & Austad, 2001; Smith et al., 2011).  
The antioxidant uric acid has been positively correlated with a long lifespan and is 
found at comparatively high levels in humans (Ames et al., 1981). Uric acid plays an 
important role in the function of vitamin C, a free radical scavenger, as well as being a 
potent free radical scavenger itself (Ames et al., 1981). Levels of uric acid in humans that 
are too high, however, can promote oxidative stress and can lead to gout and damage to 
blood vessels (So & Thorens, 2010). Birds also have high levels of uric acid when 
compared to mammals of similar body mass (Smith et al., 2011). Uric acid is the main 
end product of nitrogen metabolism in birds (Harr, 2002; Machin et al., 2004; So & 
Thorens, 2010), which when inhibited in chickens by a uric acid inhibitor (allopurinol) 
results in increased oxidative damage (Klandorf et al., 2001). It is produced mainly in the 
liver and secreted mostly in the proximal convoluted tubules of the kidneys (Harr, 2002). 
Routine levels of uric acid in bird plasma are in the range of 0.2-0.5 mM (Vleck & Vleck, 
2002). Smith et al. found levels of uric acid in mourning doves to be four times higher 
than in rats (2011). Uric acid concentrations have been proposed to play an important role 
in the antioxidant systems of birds (Iqbal et al., 1999). 
It may also be that birds can limit the consequences of AGEs formed with their 
antioxidant defenses (Holmes, Fluckiger, & Austad, 2001). Some research suggests 
greater fitness and total lifetime energy expenditures may help offset the effects of the 
characteristics mentioned above that cause oxidative damage in mammals (Hickey et al., 
2011). Bird dependence on lipid oxidation to fuel flight may also help keep ROS 
production low since this metabolic pathway results in less ROS production than 
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carbohydrate metabolism (Kuzmiak et al., 2012). Exogenous antioxidants obtained from 
the diet, such as carotenoids and various vitamins, may also play a role in the strong 
antioxidant defense systems of birds, though the true extent of their role needs further 
examination (Smith et al., 2011).  
Humans, under normal conditions, have antioxidants systems in place to prevent 
accumulation and oxidative damage from ROS (Smith et al., 2011), however, total 
antioxidant capacity decreases with age (Mecocci et al., 2000). Of note, research 
conducted with zebra finches found antioxidant capacity did not change over the lifespan 
(~7 years) of the birds, a characteristic if the same for all birds, could be another reason 
birds have low rates of oxidative stress and damage (Vleck, Haussmann & Vleck, 2007).  
IV. Effect of Diet on Protein Glycation and Formation of AGEs 
 Dietary factors that promote AGE formation. As discussed, chronic 
hyperglycemia promotes protein glycation and AGE formation. Consuming a Western-
type diet, high calorie, high fat, low fiber, combined with sedentary lifestyle, sets the 
stage for insulin resistance and chronic hyperglycemia and thus protein glycation and 
AGE formation. Nutrition also influences levels of ROS, which promote protein 
glycation; the Western diet increases oxidative stress (Ottum & Mistry, 2015). 
An interesting fact about the Western diet is that food processing and high-
temperature cooking generate AGEs and these dietary AGEs (dAGEs) are thought to 
contribute to the overall load of AGEs in the body (Alam, Ahmed & Naseem, 2015; 
Forbes et al., 2013; Kellow et al., 2014; Ottum & Mistry, 2015; Uribarri & Tuttle, 2006). 
It is estimated roughly 10% of dAGEs in food are absorbed into circulation and only 
about 1/3 are excreted by the kidneys, leaving approximately 6% to accumulate in the 
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body with endogenous AGEs and cause damage (Forbes et al., 2013; Ottum & Mistry, 
2015). AGE precursors such as CML and methylglyoxal are also created during food 
processing and can be absorbed just like AGEs (Alam, Ahmed & Naseem, 2015).  
Macronutrient composition. Much interest has been shown in the macronutrient 
composition of the diet and how it might affect weight, metabolic health and the 
development of diabetes (Forbes et al., 2013). Each macronutrient – carbohydrate, fat, 
and protein – has different effects on plasma glucose levels (Kang, Mi & Jun, 2012). 
Individuals with diabetes need to monitor carbohydrate intake as it directly affects blood 
glucose levels after meals, but a specific dietary macronutrient composition for diabetics 
remains debated (Kang, Mi & Jun, 2012). Lower carbohydrate diets have been related to 
better glycemic control, however, severe restriction of carbohydrates is related to poor 
glycemic control, most likely because it increases intake of other macronutrients, such as 
fat (Kang, Mi & Jun, 2012) which in turn promotes gluconeogenesis. High fat diets 
promote insulin resistance and glucose intolerance in mammals (Bielohuby et al., 2013). 
Animal models show diets high in fat and simple carbohydrates will induce insulin 
resistance and oxidative stress compared to a low fat and high complex carbohydrate diet 
(Barnard et al., 1998; Roberts et al., 2006). Some research indicates high protein diets 
may be marginally more effective for weight loss (Bueno et al., 2013), but others warn 
for diabetics, high protein diets, which are typically high in dAGEs, increase the load of 
AGEs in the body and lead to kidney damage (Uribarri & Tuttle, 2006). While specific 
macronutrient distribution needs further research, total caloric intake may be more 
important in the prevention and treatment of diabetes. In a study of Korean adult 
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diabetics, glycemic control was related to total energy intake and not to macronutrient 
composition (Kang, Mi & Jun, 2012).  
Protective dietary factors. Exogenous dietary antioxidants play a role in the 
body’s innate antioxidant systems to prevent oxidative damage. Diets that include a 
variety of fruits, vegetables, nuts and seeds are good sources of antioxidants such as 
vitamins A, C, and E, carotenoids, selenium and zinc (Ottum & Mistry, 2015). Most 
mammals and birds produce vitamin C endogenously, but humans must consume this 
powerful antioxidant from food. In addition to its antioxidant role, vitamin C can also 
bind to glycation sites on proteins and prevent glycation (Davie, Gould & Yudkin, 1992). 
Supplementation of vitamins C and E in diabetics has shown to decrease protein 
glycation (Ceriello et al., 1991; Davie, Gould & Yudkin, 1992). Fruits and vegetables 
contain not only vitamins and minerals but many phytochemicals, including flavonoids, 
which are thought to be protective as well by preventing oxidative stress and glycation 
(Stefek, 2011). The flavonoid quercetin, for example, is a potent scavenger of ROS and 
may prevent cataracts, a common complication of diabetes, by quenching the free radical 
intermediates involved in the glycation process (Stefek, 2011). Some research suggests 
quercetin also binds to lysine residues to prevent glycation from occurring (Alam, Ahmed 
& Naseem, 2015). Zinc, an essential element, has been shown to reduce the formation of 
Amadori products, thus decreasing the amount of AGEs produced (Tupe et al., 2015). 
Interestingly, the antioxidants Vitamins A and E, are higher in birds than in mammals 
(Schweigert et al., 1991). Mourning doves specifically were found to have higher levels 
of the carotenoid precursor to vitamin A, retinol, and other carotenoids as well as vitamin 
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E than rats (Smith et al., 2011). Carotenoids are important in birds for plumage and beak 
color (McGraw et al., 2004). 
A diet low in processed and high-heat treated foods may also be protective 
because it decreases the amount of dAGEs consumed (Forbes et al., 2013; Ottum & 
Mistry, 2015). Cooking foods at lower temperatures and with moisture helps to decrease 
the levels of dAGEs, for example, a fried, breaded chicken breast with skin contains 
about 10,000 kU/100 g AGEs (CML and methylglyoxal) while a skinless, poached 
chicken breast contains 1,000 kU/100 g (Uribarri et al., 2010). Some evidence shows 
decreasing dAGEs may be more powerful than calorie restriction for improving health 
markers such as insulin sensitivity and maintaining glucose homeostasis (Forbes et al., 
2013; Ottum & Mistry, 2015). A study by Macías-Cervantes et al. found a low dAGE diet 
in humans was just as effective at lowering serum AGEs and body fat as exercise (2015).  
V. Use of Carnivorous Birds 
 Current research in avian protein glycation. As discussed, available evidence 
suggests birds generally have lower rates of protein glycation and AGE formation. There 
is little research into avian protein glycation. Much of the work that has investigated 
protein glycation has been done with commercially-bred chickens or other domesticated 
birds such as ducks and turkeys (Holmes, Fluckiger & Austad, 2002; Szwergold & 
Miller, 2014). Chickens are easily accessible and are often used as a reference species for 
comparative studies (Myers & Klasing, 1999). Commercially-bred chickens are 
granivores, a type of herbivore, meaning they primarily eat seeds and grains and therefore 
consume a relatively high carbohydrate, low protein, low fat diet (O’Donnell, Garbett & 
Morzenti, 1978). Other herbivorous birds are frugivores, which prefer fruit, and 
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nectarivores, that primarily consume nectar. Omnivores consume both plant and animal 
matter. The jungle fowl from which chickens were domesticated from are omnivores 
because they eat both plant matter and insects (Myers & Klasing, 1999). Birds such as 
woodpeckers and cuckoos eat insects primarily and are classified as insectivores, a type 
of carnivore. Carnivores eat a diet which consists mainly of the flesh and tissues of other 
animals, which is high in protein and fat (O’Donnell, Garbett & Morzenti, 1978), and is 
very low in carbohydrate, which is consumed as glycogen or free glucose from prey 
(Myers & Klasing, 1999). Carnivorous birds, such as bald eagles, obtain meat through 
predation or scavenging (Newsome, Collins & Sharpe, 2015). For the purposes of 
research, it is important to examine questions related to glucose regulation by considering 
variations in avian dietary habits as this may provide further insight into the effects of 
diet on protein glycation.  
Protein glycation in birds of prey. As mentioned, protein glycation has been 
evaluated in only a few species of birds. These include chickens, ducks, turkeys, 
hummingbirds and budgerigars (Holmes, Fluckiger & Austad, 2002). At present, native 
protein glycation has not been evaluated in carnivorous birds of prey. It has been 
suggested carnivorous animals would be useful models of diabetes since carnivore 
metabolism induces metabolic reactions similar to pathological abnormalities observed in 
those with prediabetes or diabetes (Schermerhorn, 2013). Understanding glucose 
homeostasis and antioxidant capacity in birds of prey are thus necessary to the larger goal 
of determining how birds protect themselves from high plasma glucose concentrations 
and protein glycation.  
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 Several key differences exist between birds of prey which consume a high 
protein, high fat diet and chickens which consume a high carbohydrate, low protein, low 
fat diet. Birds of prey live longer and age slower than short-lived chickens, which age 
quickly (Holmes, Fluckiger & Austad, 2002). Birds of prey have higher fasting plasma 
glucose levels (O’Donnell, Garbett & Morzenti, 1978; Sweazea et al., 2014) and can 
maintain those levels longer than chickens during a fast or time of stress (Wallner-
Pendelton, Rogers & Epple, 1993). Minick found stress and/or fasting has little impact on 
plasma glucose levels in birds of prey (1986). This is accomplished by continuous 
gluconeogenesis in both the fed and fasting state; gluconeogenesis maintains stable 
plasma glucose levels and spares hepatic glycogen, even during a prolonged fast 
(Migliorini et al., 1973). Continuous gluconeogenesis, which uses amino acids from the 
diet in the fed state and amino acids from muscle during the fasting state, allows birds of 
prey to withstand longer periods of time between feeding compared to chickens that must 
eat more frequently (Pollock, 2002). Interestingly, barn owls given an intravenous 
glucose challenge maintained high plasma glucose levels for 3.5 hours due to 
gluconeogenesis compared to chickens, which returned to normal plasma glucose levels 
within 30 minutes (Myers & Klasing, 1999). Red-tailed hawks also take longer to return 
to normal levels than chickens after a glucose challenge (Myers & Klasing, 1999). 
O’Donnell et al. suggest the difference in plasma glucose levels between birds of prey 
and chickens is due to differences in diet (1978). Some research indicates carnivorous 
animals adapt poorly to low protein diets due to an inability to down-regulate 
gluconeogenesis, whereas omnivorous animals adapt more easily to changes in the 
macronutrient composition of the diet (Myers & Klasing, 1999).  
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 In chickens, glucagon is the predominant pancreatic glucoregulatory hormone, 
however, some research suggests insulin is more dominant in carnivorous birds (Pollock, 
2002; Sweazea et al., 2014). Removal of the pancreas results in hypoglycemia in 
chickens but in carnivorous birds results in hyperglycemia, glycosuria, and the possible 
development of diabetes (Harr, 2002; Sweazea et al., 2014; Wallner-Pendleton, Rogers & 
Epple, 1993). This may be explained by the observance that the pancreatic islets of 
Langerhans of birds of prey contain more beta cells, which produce insulin (Palmieri & 
Shivaprasad, 2014; Ruffier, Simon & Rideau, 1998), while the islets in granivorous birds 
are predominantly alpha cells, which produce glucagon (Pollock, 2002). While insulin 
concentrations are lower in carnivorous birds than in chickens, insulin in birds of prey is 
more sensitive to glucose than insulin in chickens, suggesting a higher level of insulin 
sensitivity in birds of prey (Myers & Klasing, 1999). 
 Carnivorous birds have higher metabolic rates than omnivores or granivores 
(Nagy, Girard & Brown, 1999). It might be expected that birds of prey would exhibit 
higher levels of oxidative stress, due to a higher metabolic rate, than chickens, however, 
it was found that production of free radicals in red-tailed hawks is comparable to 
chickens, with both species exhibiting lower levels of free radical production than cows 
(Conlon, Smith & Gowlett, 1991). Birds of prey have higher reference values for uric 
acid, which combined with lower free radical production, may explain the lower levels of 
oxidative stress observed (Harr, 2002).   
 Human relevance of evaluating protein glycation and antioxidant levels in birds 
of prey. As discussed, both birds as a class and carnivorous animals, in general, have 
been suggested to be used as models of diabetes for further research and insight into the 
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mechanisms of hyperglycemic damage in diabetic humans. Birds of prey are unique in 
that they fit both criteria – carnivorous birds. Studying birds of prey and how these 
species avoid diabetes and diabetic complications despite having high levels of plasma 
glucose while consuming a high protein, high fat diet, similar to the so-called Western 
diet, could generate ideas for new research into treatment options for the millions of 
people who are already afflicted with diabetes and the complications caused by protein 
glycation and AGEs. Specifically, determining what amount of protein glycation in birds 
of prey is “normal” and what levels of other protective antioxidant factors may be present 
in circulation, such as carotenoids and vitamin E, is the next logical step.  
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CHAPTER 3 
METHODS 
 Materials. Serum samples from several birds of prey (Bald Eagle (BE), Red-
Tailed Hawk (RTH), Barred Owl (BO), and Great Horned Owl (GHO)) were obtained 
from The Raptor Center, a rehabilitation center for birds of prey at the University of 
Minnesota’s College of Veterinary Medicine. The high protein, high fat diet of the birds 
of prey at the center includes rabbits, small birds, mice, rats and chickens. Diet was not 
supplemented with vitamins or minerals. Blood samples were collected from 24 birds 
(BE n=6, RTH n=7, BO n=4, and GHO n=7) and centrifuged to separate serum from 
formed elements. Body temperatures of the birds were also taken using a cloacal probe 
and body mass was recorded. Samples were shipped from the Raptor Center to Arizona 
State University overnight on dry ice and stored at -80ºC upon arrival. Chicken serum 
from one animal was donated from the Department of Animal Care and Technologies at 
Arizona State University for use as a control. All animal protocols were approved by the 
Arizona State University and University of Minnesota Institutional Animal Care and Use 
Committees (Appendices A and B).  
 Measurement of glucose levels. Plasma glucose levels were measured in all 
samples using a glucose colorimetric assay kit (Cayman Chemical, catalog #10009582). 
See Appendix C for protocol. The only deviations from the protocol were that all serum 
samples were diluted 1:15 with assay buffer prior to the assay to bring the samples within 
the range of detection and the reactions occurred at 41º C (normal body temperature of 
birds of prey), rather than mammalian-specific 37º C mentioned in the instructions. 
  56 
Glucose levels in the chicken serum were not measured as levels for chickens are well-
documented in the literature. 
Preliminary studies to determine the effects of hyperglycemic conditions on 
protein glycation. In order to assess the feasibility of incubating serum samples with 
added glucose to simulate hyperglycemic conditions, two trials were conducted. Previous 
research in Dr. Sweazea’s laboratory showed a high percentage of albumin glycation in 
samples isolated from a great horned owl after incubating the sample at 41ºC for 24 
hours. These findings suggest that either albumin is glycated as a result of oxidation (i.e. 
exposure to air outside of the body) or that glucose can auto-oxidize the protein. To rule 
out the possibility for glucose auto-oxidation, one chicken serum sample was incubated 
for 24 hours at 41ºC in a BioRad Thermocycler and stored at -80ºC until analysis by 
liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) to 
determine percent glycated albumin. A chicken sample was used for this test as prior 
research showed very little auto-oxidation of purified chicken serum albumin (J. Zuck 
Thesis, 2015). Both native glycation and glycation in the incubated serum sample were 
measured. Similar to the sample from a great horned owl, the preliminary results showed 
glycation was greater in the chicken serum sample that was incubated for 24 hours at 
41ºC as well. Thus a second trial was conducted to see if auto-oxidation could be 
prevented by adding deferoxamine (DFO), a metal chelator to the serum. For this trial, a 
sample of great horned owl serum was adjusted to achieve a final total glucose 
concentration of 400 mg/dL (i.e. hyperglycemic) using a stock solution containing 10 
mg/ml glucose prepared in 0.9% saline. A separate aliquot received the same volume of 
0.9% saline devoid of glucose. Both solutions were aliquoted in duplicate and 0.4 μl DFO 
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was added to each. The samples were then incubated at 41°C for 24 hours and resulting 
protein glycation determined by LC-ESI-MS. Baseline glycation and glycation levels 
after 24-hour incubation were measured. Results indicated high levels of glycation 
(>70%) in both incubated samples, suggesting high levels of glucose auto-oxidation even 
in the presence of the metal chelator. Therefore, experiments designed to expose serum 
from birds of prey to hyperglycemic conditions are not possible as all samples (saline vs. 
high glucose added) had very high glycation that is not representative of what happens in 
vivo. 
Measurement of native protein glycation. Percent glycation of serum albumin was 
measured in all serum samples by LC-ESI-MS in the laboratory of Dr. Chad Borges in 
the BioDesign Institute at Arizona State University. All aliquots extracted were diluted in 
a 1000:1 ratio (500 μl 0.1% trifluoroacetic acid (TFA) to 0.5 μl serum) and analyzed 
intact by LC-ESI-MS on a Dionex Ultimate 3000 HPLC equipped with a 1:100 flow 
splitter connected to a Bruker Maxis 4G quadrupole-time-of-flight (Q-TOF) mass 
spectrometer. A trap-and-elute form of LC-MS was carried out in which 25 µL diluted 
samples were loaded at 10 μl/min in 80/20 water/acetonitrile containing 0.1% formic acid 
(loading solvent) onto a Bruker-Michrom protein captrap configured for bi-directional 
flow on a 6-port diverter valve. The flow over the captrap was then switched to the 
micropump, set at 3 µL/min. A multi-step gradient was used: the first step was held at 
65% water containing 0.1% formic acid (Solvent A) / 35% acetonitrile (Solvent B) for 30 
seconds; the next step was ramped to 45% acetonitrile and held for three minutes; the last 
step was ramped to 80% acetonitrile and held for 2 minutes. The captrap eluent was 
directed to the mass spectrometer operating in positive ion, TOF-only mode, acquiring 
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spectra in the m/z range of 300 to 3000 with a nominal resolving power of ~60,000 m/Δm 
FWHM.  ESI settings for the Agilent G1385A capillary microflow nebulizer ion source 
were as follows: end plate offset -500 V, capillary -4500 V, nebulizer nitrogen 4 bar, dry 
gas nitrogen 4.0 L/min at 225 °C.  Data were acquired in profile mode at a digitizer 
sampling rate of 3 GHz. Spectra rate control was by summation at 1 Hz. 
Each serum sample eluted over a period of about 0.5 minute; under the above 
conditions, serum samples ranged in charge state from +33 to +68.  Raw mass spectra 
were averaged across this timeframe, baseline subtracted 0.7, charge deconvoluted with 
Bruker DataAnalysis 4.1 charge deconvolution software to a mass range of 1000 Da on 
either side of any identified peak (see Appendix D). 
For each species, the peak counts corresponding to the peaks for native albumin 
(in Da: BE ~66895; RTH ~66753; BO ~67303; GHO ~67351; chicken ~66874), glycated 
albumin (in Da: BE ~67057; RTH ~66916; BO ~67464; GHO ~67512; chicken ~67036), 
and doubly glycated albumin (in Da: BE ~67207; RTH ~67074; BO ~67624; GHO 
~67674; chicken ~67198) were obtained from the mass spectra and used in the following 
formula to calculate percent glycated albumin: Percent Glycated Serum Albumin = 
{[glycated albumin + 2(doubly glycated albumin)] / [native albumin + glycated albumin 
+ doubly glycated albumin]} * 100. 
Measurement of potential vasoprotective factors. In general, birds reportedly have 
higher circulating antioxidants as compared to mammals (Smith et al., 2011). These 
antioxidants may protect birds from protein glycation in vivo. Uric acid levels were 
measured in all samples (QuantiChrom uric acid assay kit, catalog #DIUA-250). See 
appendix E for the protocol. The only deviation from protocol is all samples were diluted 
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1:2 to bring them within the range of detection. Various exogenous antioxidants were 
also measured in the samples. These antioxidants included vitamin E, retinol and 
carotenoids (lutein, zeaxanthin, anhydrolutein, beta-cryptoxanthin and beta-carotene), 
measured by high performance liquid chromatography (HPLC) in the laboratory of Dr. 
Kevin McGraw at Arizona State University. Refer to Giraudeau et al. for HPLC protocol 
followed (2013). 
Statistical analysis. Data were analyzed using one-way ANOVA. When 
significance was indicated, Dunn’s or Tukey post hoc analyses were used. Data are 
expressed as means ± SEM. Data for glucose, % glycation, retinol, anhydrolutein and 
uric acid were normally distributed and passed equal variance testing. Data for vitamin E, 
lutein and zeaxanthin were not normally distributed and were log transformed to 
approximate a normal distribution before analyzing using one-way ANOVA. The data for 
the carotenoids beta-cryptoxanthin and beta-carotene were also not normally distributed, 
however, because several values were 0.0, the data could not be log transformed, 
therefore was analyzed using Kruskal-Wallis one-way ANOVA on ranks. All statistical 
analyses were performed using SigmaPlot 10.0/SigmaStat 3.0. A p-value of ≤ 0.05 was 
considered statistically significant for all comparisons.  
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CHAPTER 4 
RESULTS 
Measurement of serum glucose levels. Serum glucose levels were similar between 
all birds (in mM/L: BE 20.05 ± 0.81; RTH 22.24 ± 0.93; BO 19.93 ± 1.57; GHO 21.52 ± 
1.38) and were not significantly different (p = 0.387; see Figure 3A). 
Measurement of % protein glycation. Statistical analyses showed significant 
between group differences in percent protein glycation. Glycation was significantly 
higher (p < 0.001) in BE (23.67 ± 1.90%) and BO (24.28 ± 1.43%) compared to RTH 
(14.31 ± 0.63%). Percent glycation for GHO was 19.12 ± 1.82% (see Figure 3B). For 
comparison, the percent albumin glycation for the chicken sample was 11.79%. 
 
Fig. 3 Comparison of glucose and % albumin glycation levels. (A) Serum glucose levels. 
Levels were similar between all species (p = 0.387). (B) BE and BO both had 
significantly higher levels of protein glycation compared to RTH; * p < 0.001 
 
Measurement of vasoprotective factors. Uric acid levels were not significantly 
different (p = 0.355) between species (in mg/dL: BE 9.10 ± 1.30; RTH 10.05 ± 1.24; BO 
12.95 ± 2.40; GHO 11.24 ± 1.07). Vitamin E and retinol levels were also not significantly 
different (p = 0.687 and p = 0.06, respectively) between species (in mg/dL: BE 6.60 ± 
0.68, 5.40 ± 0.83; RTH 6.67 ± 0.52; 7.94 ± 0.47; BO 7.21 ± 0.15, 5.55 ± 1.01; GHO 7.22 
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± 0.52, 6.70 ± 0.70). Of the carotenoids tested, beta-cryptoxanthin and beta-carotene 
levels were significantly greater in BE (0.59 ± 0.17; 0.41 ± 0.08 μg/ml) compared to 
GHO (0.02 ± 0.02; 0 μg/ml; p = 0.004) and RTH (0.02 ± 0.02; 0.01 ± 0.01 μg/ml; p = 
0.001). BE and BO had significantly greater (p = 0.001) levels of lutein (6.38 ± 0.75 
μg/ml; 14.54 ± 4.23 μg/ml) compared to GHO (1.96 ± 0.50 μg/ml) and RTH (2.81 ± 0.93 
μg/ml). Anhydrolutein and zeaxanthin levels were not significantly different (p = 0.054 
and p = 0.084, respectively) between the species (in μg/ml: BE 1.83 ± 0.51, 2.21 ± 0.50; 
RTH 0.82 ± 0.16, 1.51 ± 0.79; BO 1.49 ± 0.65, 6.63 ± 2.48; GHO 0.34 ± 0.095, 1.30 ± 
0.26). See figure 4 (A-H) for a summary of the results.  
Results for the chicken sample were as follows: uric acid 6.53 mg/dL; vitamin E 
3.01 μg/ml; retinol 4.34 μg/ml; lutein 9.81 μg/ml; zeaxanthin 3.43 μg/ml; anhydrolutein 
0.30 μg/ml; beta-cryptoxanthin 0.20 μg/ml; beta-carotene 0.04 μg/ml. 
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Fig. 4 Levels of vasoprotective factors. (A) Uric acid levels were not significantly 
different between species (p = 0.355). (B) Vitamin E levels were not significantly 
different between species (p = 0.589). (C) Retinol levels were not significantly different 
between species (p = 0.06). (D) Lutein levels were significantly greater in BO compared 
to GHO (*p = 0.008). (E) Zeaxanthin levels were not significantly different between 
species (p = 0.171). (F) Anhydrolutein levels were not significantly different between 
species (p = 0.054). (G) Beta-cryptoxanthin levels were significantly greater in BE 
compared to both RTH and GHO (*p = 0.004). (H) Beta-carotene levels were 
significantly greater in BE compared to RTH and GHO (*p = 0.001)  
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CHAPTER 5 
DISCUSSION 
Discussion of results. This study evaluated glucose, percent albumin glycation 
and several antioxidant levels in birds of prey with the aim of comparing the results to 
what has been observed in other species. Specifically, interest is in evaluating differences 
in these parameters which may exist between species that have vastly different diets. 
The serum glucose levels for the birds of prey in this study ranged from 15.7 – 
24.6 mM/L (282.6 – 442.8 mg/dL), which is similar to previously published values 
(O’Donnell, Garbett & Morzenti, 1978). Published chicken plasma glucose levels are 
reported between 218 – 264 mg/dL (O’Donnell, Garbett & Morzenti, 1978; Rendell et al., 
1985). While both values are well above levels that would be considered normal in 
humans, the birds of prey have higher glucose concentrations than chickens. Diet is 
thought to play a major role in this difference; a carnivorous diet is low in carbohydrates 
and spurs a continuous state of gluconeogenesis that maintains high plasma glucose 
concentrations for an ever ready supply of glucose (O’Donnell, Garbett & Morzenti, 
1978). Research indicates carnivores are less adaptable to carbohydrate-rich diets because 
of an inability to down-regulate gluconeogenesis even in the fed state (Myers & Klasing, 
1999).  
No studies to date have evaluated protein glycation in birds of prey. Therefore, 
this study is the first to measure albumin glycation in serum samples from four different 
species of birds of prey. The first hypothesis of this study stating that native protein 
glycation would be higher in birds of prey as compared to chickens due to their high 
protein, high fat diet with limited ingestion of antioxidants is supported by the results. 
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Rendell et al. reported a 2.35 ± 0.17% for chickens compared to 1.50 ± 0.05% in humans. 
This is interesting given hemoglobin, other glycated proteins and AGEs studied in birds 
(chickens, ducks, turkeys and hummingbirds) are much lower than what is found in 
humans, meaning although albumin glycation may be higher in chickens compared to 
humans, total overall glycation and AGE formation in birds is lower than in humans 
despite the naturally high glucose concentrations measured for these birds (Holmes, 
Fluckiger & Austad, 2001). In non-diabetic humans, albumin glycation can be between 1-
10% in vivo, however one study reported a mean of 13.4 ± 2.3% in healthy individuals 
(Rondeau & Bourdon, 2011). The results of the present study show albumin glycation 
levels in bald eagles (23.67 ± 1.9%), barred owls (24.28 ± 1.43%) and great horned owls 
(19.12 ± 1.82%) that are above this range and, in fact, are comparable to what is seen in 
diabetic humans; reported means for type 1 diabetics are 25.8 ± 5.6 % and for type 2 
diabetics 23.1 ± 4.4% (Rondeau & Bourdon, 2011). Interestingly, statistical analysis 
showed significant between species differences in the birds of prey. Both bald eagles and 
barred owls showed greater glycation than red-tailed hawks. Red-tailed hawks had a 
significantly lower level of albumin glycation (14.3 ± 0.63%), despite having the highest 
mean glucose levels (22.24 mM/L), compared to bald eagles and barred owls, and was 
similar to what has been reported in non-diabetic humans. Species variation in albumin 
glycation may be due to differences in albumin turnover rates; some research has shown 
that glycated albumin is more quickly degraded than unmodified albumin in rabbits and 
dogs (Kallner, 1990; Morris & Preddy, 1986). If red-tailed hawks turn over glycated 
albumin more quickly than the other birds of prey species, that might explain the 
significantly lower glycation levels compared to bald eagles and barred owls.  
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Alternatively, it is possible that the albumin protein may be folded differently in 
red-tailed hawks thus potentially shielding lysine residues from glycation or that red-
tailed hawks have fewer lysine residues available for glycation. Identification of the 
albumin sequence and three-dimensional structure for the species examined in the current 
study was outside the scope of this thesis. However, a comparison of the protein 
sequences for humans, chickens and several other species of birds including one bird of 
prey is included in Appendix F. From this simple comparison, it is evident that the barn 
owl albumin does indeed have two variations in which a lysine residue typically 
expressed and known to be glycated in human samples are missing from the owl 
sequence (Lys 199 and Lys 519 (shown as Lys 543 in the alignment program); Anguizola 
et al., 2013). Thus it is possible that the red-tailed hawk albumin has similar and perhaps 
additional variations.  
Protein glycation is promoted by oxidative stress. Also, the formation of AGEs 
involves oxidative steps and the interaction of AGEs with their receptors, such as RAGE, 
causes oxidative stress and damage. Thus, antioxidants play an important role in limiting 
and quenching oxidative damage. One such endogenous antioxidant that may help protect 
birds from oxidative damage is uric acid (Vleck, Haussmann & Vleck, 2007). Typical 
levels of uric acid in birds are 3.6 – 9 mg/dL (Vleck & Vleck, 2002), however, 
carnivorous birds have higher reference values for uric acid than other birds (Harr, 2002). 
The results from the present study confirm the higher reference values for uric acid in 
birds of prey as values range from 5.5 – 17.3 mg/dL. Birds of prey have higher levels of 
uric acid owing to a diet that is high in protein as increased protein metabolism and 
catabolism produces higher levels of uric acid. Machin et al. found that chickens fed a 
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high protein diet exhibited increased levels of uric acid compared to chickens that ate a 
low or moderate protein diet (2004). Since levels of uric acid are influenced by the 
amount of protein in the diet, it would be expected that birds of prey, which consume a 
high protein diet, would have high serum uric acid levels. Indeed, the results of the 
present study support the second hypothesis that uric acid levels would higher in birds of 
prey than chickens due to higher ingestion and utilization of protein for energy.  
High levels of uric acid do not appear to be pathological to birds. For humans, 
uric acid is similarly an antioxidant. However, levels of uric acid above 7.2 mg/dL are 
pro-oxidant and can cause gout in humans (Ottum & Mistry, 2015; So & Thorens, 2010). 
Increased uric acid levels in diabetics may contribute to diabetic kidney disease 
(American Diabetes Association, 2014) and are associated with increased risk for stroke 
(Engstrom et al., 2002), atherosclerosis and hypertension (Ottum & Mistry, 2015). Insulin 
resistant individuals experience abnormal uric acid metabolism (Wilcox, 2005). A diet 
high in red meat, fried food, sweetened beverages and alcohol promotes elevated uric 
acid levels, while a diet rich in fruits, vegetables, nuts, seeds and vitamin C is associated 
with lower levels of uric acid (Ottum & Mistry, 2015). If uric acid retains its antioxidant 
capabilities even at high levels in birds, this may help explain the lower rates of oxidative 
stress and protein glycation observed despite the naturally high glucose concentrations. 
Vitamin E is the collective name for a group of lipid soluble vitamins and 
antioxidants produced by plants that must be obtained from the diet (Falk & Munne-
Bosch, 2010; Hidiroglou et al., 1992). Plant oils from grains, nuts, seeds and foods they 
are produced with are the primary source of this vitamin in the human diet, however, 
milk, eggs and fatty tissues of animals contain small amounts as well (Bramley et al., 
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2000; Gropper & Smith, 2013). In addition to its antioxidant properties, vitamin E has 
been shown to help prevent glycation in vitro (Vinson & Howard, 1996) and to reduce 
protein glycation in diabetics (Ceriello et al., 1991). It has been reported vitamin E levels 
are higher in birds than in mammals, possibly due to higher lipid levels in the plasma 
(Schweigert et al., 1991). For example, mourning doves have been shown to have higher 
levels of vitamin E than rats (Smith et al., 2011). It has also been reported that birds of 
prey have higher levels of α-tocopherol, an important vitamin E compound, than 
herbivorous birds like chickens (Muller et al., 2011), although normal α-tocopherol levels 
are unknown (Calle, 1989). Research that has measured plasma α-tocopherol levels in 
captive birds of prey has shown a great deal of variability ranging from 1.95 – 40.7 μg.ml 
(Schweigert et al., 1991). Another study showed captive raptors supplemented with 
vitamin E reached plasma α-tocopherol levels between 12.3 – 849 μg/ml (Calle et al., 
1989) whereas a study of 20 free-living bald eagles reported α-tocopherol levels of 24 
μg/ml or more (Dierenfeld, 1989). Species-specific differences may play a role in the 
varying levels of plasma vitamin E observed in birds (Calle 1989), however, the birds of 
prey in this study had similar mean vitamin E levels (bald eagle 6.60 μg/ml, red-tailed 
hawk 6.67 μg/ml, barred owl 7.21 μg/ml and great horned owl 7.21 μg/ml) and were not 
significantly different from each other. The bald eagle mean value is less than what 
Dierenfeld reported for free-living bald eagles, but the difference may be due to diets 
obtained in captivity which were similar to all birds in the current study versus variations 
in food availability in the wild. 
 Retinol is one of a group of compounds that comprise vitamin A. It can be 
obtained from animal sources in the diet, such as liver, dairy and eggs, or from certain 
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carotenoids from plant sources, such as colorful fruits and vegetables, which are 
converted to retinol during digestion and absorption (Gropper & Smith, 2013). Some 
research has shown retinol levels are higher in birds and carnivores compared to non-
carnivorous mammals (Schweigert et al., 1991). For example, Smith et al. (2011) found 
mourning doves had significantly higher levels of retinol than rats while Schweigert et al. 
(1991) found bats had only trace amounts. Birds of prey and carnivorous mammals may 
have higher levels of retinol due to diet; liver and other organs from prey are good 
sources of the vitamin, in fact, captive carnivores fed an all-meat diet without liver or 
supplementation will develop vitamin A deficiency diseases (Ghebremeskel & Williams, 
1988; Morishita, Aye & Brooks, 1997). Schweigert et al. found chickens had a retinol 
mean value of 0.797 ± 0.214 μg/ml (1991). The chicken sampled in this study had a value 
of 4.34 μg/ml. While references for the species in this study are not available in the 
literature, Wallace et al. found Humboldt penguins had values ranging from 0.352 – 
2.049 μg/ml (1996). The retinol levels measured in this study are greater (3.13 – 10.59 
μg/ml) than these referenced values. A study of captive Psittacine birds found that retinol 
levels, as well as vitamin E levels, vary between subclass and genera (Torregrossa, 2005), 
therefore wide inter- and intraspecies variation in retinol levels can be expected and may 
explain the variation noted here.  
Carotenoids are only synthesized by plants and must come from the diet (Brush, 
1990). These compounds are important to birds for overall health, breeding and 
coloration (McGraw, 2006). Some carotenoids can be converted to retinol; both beta-
carotene and beta-cryptoxanthin are precursors to vitamin A (Gropper & Smith, 2013). 
An important physiological function of carotenoids is to quench free radicals and prevent 
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oxidative damage (Gropper & Smith, 2013). Little is known about the dietary 
requirements or serum plasma levels of carotenoids in birds of prey (Blanco et al., 2013). 
Research in penguins, pelicans, gulls and terns have shown lutein and zeaxanthin to be 
the major carotenoids found in serum (Slifka, 1999). Wallace et al. found the greatest 
circulating carotenoid in Humboldt penguins was lutein (1996). Based on the results of 
this study, the same is true for bald eagles, red-tailed hawks, barred owls, great horned 
owls, and the chicken sample, with all species showing lutein as the most abundant 
carotenoid, followed by zeaxanthin. Although lutein was the most abundant carotenoid, 
there was high variability in the mean values between the species examined in the current 
study with bald eagles (6.38 ± 0.75 μg/ml) and barred owls (14.542 ± 8.461 μg/ml) 
having significantly greater levels than great horned owls (1.962 ± 1.108 μg/ml) and red-
tailed hawks (2.81 ± 0.93 μg/ml). Bald eagles had significantly greater levels of beta-
carotene and beta-cryptoxanthin than both red-tailed hawks and great horned owls. Due 
to the high variability in carotenoid levels between the birds of prey species and the 
chicken sample, the third hypothesis that carotenoid and antioxidant levels will be lower 
in birds of prey than in chickens due to low ingestion of antioxidants is not supported. 
Since carotenoids must come from the diet, dietary preference affects levels of 
carotenoids in serum. However, other factors also affect carotenoid levels such as type of 
species, sex, age and seasonal variations in physiologic state and food availability 
(Blanco et al., 2013; Cohen, McGraw & Robinson, 2009; Wallace et al., 1996). 
Differences also exist in carotenoid levels between captive and wild birds; Andean 
condors living in captivity fed an all-meat diet had carotenoid levels 13% lower than their 
wild counterparts (Negro et al., 2002). It is suggested wild birds can forage vegetal matter 
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or herbivore excrement to meet carotenoid needs, whereas captive birds do not have this 
option (Blanco et al., 2014; Negro et al., 2002). Still more differences exist in carotenoid 
absorption and metabolism between species; exact biochemical mechanisms need to be 
elucidated (Blanco et al., 2013; Blanco et al., 2014). Since the birds of prey in this study 
were fed the same diet, lived in the same location and had blood drawn within the same 
time period, differences in biochemical parameters (carotenoid absorption, enzyme 
differences, different biological needs) may explain the differences in carotenoid levels 
observed. 
Strengths and Limitations. This study had several strengths. All serum samples 
from birds of prey came from animals housed at the same facility. Thus, the diet and life 
history of the birds was known. Percent glycation was measured using liquid 
chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) which can 
measure both glycated and doubly glycated albumin allowing for more accurate 
measurements of total percent glycated albumin. Additionally, carotenoids and vitamins 
A and E were measured using a well-documented method for avian samples allowing for 
between species comparisons. 
Despite these strengths, some limitations exist. The study only collected serum 
samples from the animals, thus the results cannot be extrapolated to the whole animal or 
other birds, animals or humans. The use of serum from captive birds, as opposed to wild 
birds, is another limitation. Daily activities and life histories of captive birds differ from 
those of wild birds, thus the findings cannot be extrapolated to wild birds. Another 
limitation was not having the ability to manipulate the diet of the birds to determine a 
direct link between dietary modifications and glycation. Also, while the diet of the birds 
  71 
of prey consisted of small animals, it may not be representative of the type and timing of 
feedings the birds of prey would experience in the wild. Some evidence suggests wild 
birds will ingest unusual food sources when driven by nutrient need, however, this is not 
an option for captive birds. Because of inherent physiological differences between 
mammals and birds, findings from this study may not directly influence 
recommendations for humans, but may be used as a guide for further research and 
investigation.  
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CHAPTER 6 
CONCLUSIONS AND APPLICATIONS 
 The results of this study have shown that birds of prey have metabolic similarities 
to diabetic humans. Both populations have high serum glucose concentrations. Birds of 
prey are more sensitive to insulin (unlike chickens) yet produce smaller amounts than 
healthy humans, a condition that mimics insulin resistance in diabetic humans. In this 
study bald eagles, barred owls and great horned owls exhibited similar levels of albumin 
glycation to what has been found in diabetic humans. For humans, chronically high 
serum glucose concentrations and insulin resistance lead to the development of diabetes, 
with high levels of protein glycation leading to the formation of AGEs. For birds of prey, 
however, this metabolic state is natural and they remain healthy and pathology-free. 
These similarities make birds of prey an excellent model of diabetes.  
 Even more intriguing are the results of this study that showed that while red-tailed 
hawks had the highest serum glucose levels, they had the lowest levels of albumin 
glycation. One possible explanation is that red-tailed hawks turn over glycated albumin 
more quickly than the other species in the study. Another explanation may be that the 
structure of albumin varies among the other species and humans. The protein may be 
folded differently in red-tailed hawks, thus shielding lysine residues from glycation. Also, 
it is possible that red-tailed hawks have fewer lysine residues available for glycation than 
the other species. The comparison of proteins sequences between humans, chickens and 
other birds, including barn owls, showed that owl albumin has variations in which lysine 
residues typically expressed and known to be glycated in human samples are missing 
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from the owl sequence. More research is needed to investigate the structural differences 
in albumin between bird of prey species and humans. 
 Since protein glycation is greatly affected by, and also produces oxidative stress, 
it is important to research factors that prevent oxidative damage from occurring. Protein 
glycation, AGEs and ROS can form a vicious cycle, with each promoting the other. This 
study evaluated the levels of certain known antioxidants. Antioxidants are of great 
interest because they quench ROS and thus limit oxidative damage. Birds of prey, which 
consume a high protein diet, have higher reference values for uric acid and the results of 
this study supported those values. The other antioxidants evaluated in this study – vitamin 
E, retinol and several carotenoids – are an interesting area of research in that these 
compounds are provided by the diet, thus differences in dietary composition affect levels 
observed. Direct comparison of each antioxidant between species and other birds and 
mammals is difficult given that normal levels have not been established for most species. 
Further complicating the issue within animal research are the differences in diet and life 
histories between captive and wild animals. More research is needed to investigate 
optimal levels of antioxidants in both captive and wild birds of prey in order to properly 
evaluate how a carnivorous diet affects antioxidant levels and protein glycation. 
 This research has significant human relevance. Studying birds of prey and how 
these species avoid diabetes and diabetic complications despite having high levels of 
plasma glucose while consuming a high protein diet could generate ideas for new 
research into treatment options for the millions of people who are already afflicted with 
diabetes and the complications caused by protein glycation and AGEs. Understanding the 
underlying mechanisms that protect birds from developing the complications associated 
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with diabetes could help develop new treatments and/or drugs that prevent glycation and 
thus the damaging effects of AGEs. Research into how specific diets affect protein 
glycation is of interest, given that dietary interventions can be a simple and cost-effective 
treatment.   
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APPENDIX A  
THE UNIVERSITY OF MINNESOTA’S INSTITUTIONAL ANIMAL CARE AND 
USE COMMITTEE (IUCAC) APPROVAL  
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APPENDIX B 
ARIZONA STATE UNIVERSTIY’S INSTITUTIONAL ANIMAL CARE AND USE 
COMMITTEE (IACUC) APPROVAL 
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APPENDIX C 
PROTOCOL FOR GLUCOSE COLORIMETRIC ASSAY KIT 
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APPENDIX D 
PROTOCOL FOR LC-ESI-MS ANALYSIS OF BIRD OF PREY AND CHICKEN 
SERUM SAMPLES FOR PERCENT GLYCATION 
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LC-ESI-MS Machine Preparation: 
1. Turn MS from ‘stand-by’ mode to ‘operate’ mode 
2. Change loading flow from 3μl/min to 10μl/min and change micro flow from 
0.105μl/min to 3μl/min 
3. Screw in the connection between the LC and MS 
4. Clean source using methanol and water; clean needle using methanol and water 
 
Sample Preparation: 
1. Prepare 5ml 0.1% TFA by combining 4.95ml distilled H2O with 50μl 10% TFA 
stock solution 
2. Remove sample from -80°C 
3. Centrifuge sample for 60 seconds at 14 RPM 
4. Prepare 1000:1 dilution of raptor sample by combining 500μl 0.1% TFA with 
0.5μl sample. Vortex diluted sample 
5. Load 25μl of the diluted sample into one well of the 96-well plate 
6. Load 50μl of 0.1% TFA into a separate well of the 96-well plate 
7. Load 96-well plate onto the plate-holder of the LC-MS 
8. Acquisition the two wells as follows: 
a. Sample well- 
i. Injections: 1 
ii. Amount: 10.000μl  
iii. LC Method Part: alb apoai captrap step grad 35 45 80 
iv. Autosampler Method Part: Standard 
v. MS Acquisition Method Part: 160605 has optimized for 3 mclmin 
b. Solvent well- 
i. Injections: 1 
ii. Amount: 10.000μl  
iii. LC Method Part: alb apoai captrap step grad 35 45 80 
iv. Autosampler Method Part: Standard 
v. MS Acquisition Method Part: 160605 has optimized for 3 mclmin 
 
Spectra Analysis (Albumin): 
1. Open Spectra in Compass DataAnalysis 
2. Run method: Albumin 
3. Uncheck BPC and All MS 
4. Edit Chromatogram to add Total Ion Chromatogram (TIC) 
5. Average raw spectra across the approximate 0.5 min timeframe of sample elution 
6. Copy to compound spectra 
7. Baseline subtraction (0.7) 
8. Charge Deconvolution 
9. Record the mass (m/z) and counts for the relevant peaks for samples (native 
albumin, glycated albumin, and doubly glycated albumin) 
10. Calculate Percent Glycated Albumin for each spectrum using the appropriate 
counts 
11. Save spectra 
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APPENDIX E 
PROTOCOL FOR URIC ACID ASSAY 
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APPENDIX F 
COMPARISON OF THE PROTEIN SEQUENCES FOR HUMANS, CHICKENS AND 
SEVERAL OTHER SPECIES OF BIRDS INCLUDING ONE BIRD OF PREY 
PREPARED USING THE CONSTRAINT-BASED MULTIPLE ALIGNMENT TOOL 
(COBALT) PROGRAM FROM NCBI (NATIONAL CENTER FOR 
BIOTECHNOLOGY INFORMATION) 
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